SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16 of the
Securities Exchange Act of 1934
For the month of May, 2018
Commission File Number 1565025
AMBEV S.A.
(Exact name of registrant as specified in its charter)
AMBEV S.A.
(Translation of Registrant's name into English)
Rua Dr. Renato Paes de Barros, 1017 - 3rd Floor
04530-000 São Paulo, SP
Federative Republic of Brazil
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
Form 20-F ___X___ Form 40-F _______
Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes _______ No ___X____
INTERIM CONSOLIDATED FINANCIAL STATEMENTS - AMBEV S.A.
Interim Consolidated Balance Sheets
As at March 31, 2018 and
December 31, 2017
(Expressed in thousands of Brazilian Reais)
Assets
|
Note
|
03/31/2018
|
12/31/2017
|
|
|
|
|
Cash and cash equivalents
|
5
|
7,953,477
|
10,354,527
|
Investment securities
|
6
|
12,229
|
11,883
|
Derivative financial instruments
|
20
|
366,507
|
350,036
|
Trade receivable
|
|
3,537,112
|
4,944,831
|
Inventories
|
7
|
4,725,117
|
4,318,973
|
Income tax and social contributions recoverable
|
|
2,962,627
|
2,770,376
|
Other recoverable taxes
|
|
712,424
|
600,165
|
Other assets
|
|
1,291,059
|
1,367,282
|
Current assets
|
|
21,560,552
|
24,718,073
|
|
|
|
|
|
|
|
|
Investment securities
|
6
|
143,481
|
121,956
|
Derivative financial instruments
|
20
|
41,440
|
35,188
|
Income tax and social contributions recoverable
|
|
2,322,283
|
2,312,664
|
Other recoverable taxes
|
|
200,664
|
225,036
|
Deferred tax assets
|
8
|
2,348,581
|
2,279,339
|
Other assets
|
|
1,389,186
|
1,964,424
|
Employee benefits
|
|
54,116
|
58,443
|
Investments in joint ventures
|
|
243,813
|
237,961
|
Property, plant and equipment
|
9
|
18,276,310
|
18,822,327
|
Intangible
|
|
4,606,773
|
4,674,704
|
Goodwill
|
10
|
31,191,746
|
31,401,874
|
Non-current assets
|
|
60,818,393
|
62,133,916
|
|
|
|
|
Total assets
|
|
82,378,945
|
86,851,989
|
The accompanying notes are an integral part of these interim consolidated financial statements.
Interim Consolidated Balance Sheets (continued)
As at March 31, 2018 and
December 31, 2017
(Expressed in thousands of Brazilian Reais)
Equity and liabilities
|
Note
|
03/31/2018
|
12/31/2017
|
|
|
|
|
Trade payables
|
|
11,000,925
|
11,853,928
|
Derivative financial instruments
|
20
|
267,738
|
215,090
|
Interest-bearing loans and borrowings
|
11
|
3,278,899
|
1,321,122
|
Bank overdrafts
|
5
|
127
|
1,792
|
Wages and salaries
|
|
779,945
|
1,047,182
|
Dividends and interest on shareholders’ equity payable
|
|
747,105
|
1,778,633
|
Income tax and social contribution payable
|
|
1,506,236
|
1,668,407
|
Taxes and contributions payable
|
|
2,390,814
|
3,825,440
|
Put option granted on subsidiary and other liabilities
|
|
2,709,787
|
6,807,925
|
Provisions
|
12
|
168,731
|
168,957
|
Current liabilities
|
|
22,850,307
|
28,688,476
|
|
|
|
|
Trade payables
|
|
145,514
|
175,054
|
Derivative financial instruments
|
20
|
30,407
|
2,434
|
Interest-bearing loans and borrowings
|
11
|
1,188,756
|
1,231,928
|
Deferred tax liabilities
|
8
|
2,377,971
|
2,329,229
|
Income tax and social contribution payable
(i)
|
|
2,185,225
|
2,418,027
|
Taxes and contributions payable
|
|
746,145
|
771,619
|
Put option granted on subsidiary and other liabilities
|
|
345,715
|
429,102
|
Provisions
|
12
|
490,155
|
512,580
|
Employee benefits
|
|
2,250,502
|
2,310,685
|
Non-current liabilities
|
|
9,760,390
|
10,180,658
|
|
|
|
|
Total liabilities
|
|
32,610,697
|
38,869,134
|
|
|
|
|
Equity
|
13
|
|
|
Issued capital
|
|
57,710,202
|
57,614,140
|
Reserves
|
|
63,302,193
|
63,361,144
|
Carrying value adjustments
|
|
(74,349,103)
|
(74,966,470)
|
Retained earnings
|
|
2,160,529
|
-
|
Equity attributable to equity holders of Ambev
|
|
48,823,821
|
46,008,814
|
Non-controlling interests
|
|
944,427
|
1,974,041
|
Total Equity
|
|
49,768,248
|
47,982,855
|
|
|
|
|
Total equity and liabilities
|
|
82,378,945
|
86,851,989
|
The accompanying notes are an integral part of these interim consolidated financial statements.
Interim Consolidated Income Statements
For
the three-month period ended March 31, 2018 and 2017
(Expressed in thousands of Brazilian
Reais)
|
Note
|
03/31/2018
|
03/31/2017
|
|
|
|
|
Net sales
|
15
|
11,640,219
|
11,241,805
|
Cost of sales
|
|
(4,460,748)
|
(4,523,141)
|
Gross profit
|
|
7,179,471
|
6,718,664
|
|
|
|
|
Distribution expenses
|
|
(1,623,818)
|
(1,511,444)
|
Sales and marketing expenses
|
|
(1,471,470)
|
(1,413,786)
|
Administrative expenses
|
|
(572,143)
|
(555,659)
|
Other operating income/(expenses), net
|
16
|
257,560
|
290,826
|
Exceptional items
|
|
(8,432)
|
(28,694)
|
Income from operations
|
|
3,761,168
|
3,499,907
|
|
|
|
|
Finance cost
|
17
|
(919,834)
|
(996,258)
|
Finance income
|
17
|
375,541
|
123,663
|
Net finance cost
|
|
(544,293)
|
(872,595)
|
|
|
|
|
Share of result of joint ventures
|
|
617
|
1,032
|
Income before income tax
|
|
3,217,492
|
2,628,344
|
|
|
|
|
Income tax expense
|
18
|
(619,863)
|
(338,513)
|
Net income
|
|
2,597,629
|
2,289,831
|
|
|
|
|
Attributable to:
|
|
|
|
Equity holders of Ambev
|
|
2,515,962
|
2,199,135
|
Non-controlling interests
|
|
81,667
|
90,696
|
|
|
|
|
Basic earnings per share – common - R$
|
|
0.16
|
0.14
|
Diluted earnings per share – common - R$
|
|
0.16
|
0.14
|
The accompanying notes are an integral part of these interim
consolidated financial statements.
Interim Consolidated
Statements of Comprehensive Income
For
the three-month period ended March,31, 2018 and 2017
(Expressed in thousands of Brazilian Reais)
|
03/31/2018
|
03/31/2017
|
|
|
|
Net income
|
2,597,629
|
2,289,831
|
|
|
|
Items that will not be recycled to profit or loss:
|
|
|
Full recognition of actuarial gains/(losses)
|
(3,189)
|
159,127
|
|
|
|
Items that may be recycled subsequently to profit or
loss:
|
|
|
Exchange differences on translation of foreign
operations (gains/(losses)
|
|
|
Investment hedge - put option granted on subsidiary
|
57,390
|
128,792
|
Gains/losses on translation of other foreign
operations
|
(449,961)
|
(611,599)
|
Gains/losses on translation of foreign operations
|
(392,571)
|
(482,807)
|
|
|
|
Cash flow hedge - gains/(losses)
|
|
|
Recognized in Equity (Hedge reserve)
|
43,008
|
(96,114)
|
Removed from Equity (Hedge reserve) and included in
profit or loss
|
(99,931)
|
203,341
|
Total cash flow hedge
|
(56,923)
|
107,227
|
|
|
|
Other comprehensive (loss)/income
|
(452,683)
|
(216,453)
|
|
|
|
Total comprehensive income
|
2,144,946
|
2,073,378
|
|
|
|
Attributable to:
|
|
|
Equity holders of Ambev
|
2,064,634
|
2,024,718
|
Non-controlling interest
|
80,312
|
48,660
|
The accompanying notes are an integral part of these interim
consolidated financial statements. The consolidated statements of comprehensive
income are presented net of income tax. The income tax effects of these items
are disclosed in note 8 -
Deferred income tax and social contribution.
Interim Consolidated Statements of Changes in Equity
For the
three-month period ended March,31, 2018 and 2017
(Expressed in thousands of Brazilian Reais)
|
Attributable to equity holders of Ambev
|
|
|
|
|
Capital
|
Capital reserves
|
Net income reserves
|
Retained earnings
|
Carrying value adjustments
|
Total
|
|
Non-controlling interests
|
Total equity
|
At December 31, 2017
|
57,614,140
|
54,700,909
|
8,660,235
|
-
|
(74,966,470)
|
46,008,814
|
|
1,974,041
|
47,982,855
|
Impact of the adoption of IFRS 15
(i)
|
-
|
-
|
-
|
(355,383)
|
-
|
(355,383)
|
|
-
|
(355,383)
|
At January 1, 2018
|
57,614,140
|
54,700,909
|
8,660,235
|
(355,383)
|
(74,966,470)
|
45,653,431
|
|
1,974,041
|
47,627,472
|
|
|
|
|
|
|
|
|
|
|
Net Income
|
-
|
-
|
-
|
2,515,962
|
-
|
2,515,962
|
|
81,667
|
2,597,629
|
|
|
|
|
|
|
|
|
|
|
Comprehensive income:
|
|
|
|
|
|
|
|
|
|
Gains/(losses) on translation of foreign operations
|
-
|
-
|
-
|
-
|
(392,994)
|
(392,994)
|
|
423
|
(392,571)
|
Cash flow hedges
|
-
|
-
|
-
|
-
|
(55,743)
|
(55,743)
|
|
(1,180)
|
(56,923)
|
Actuarial gains/(losses)
|
-
|
-
|
-
|
-
|
(2,591)
|
(2,591)
|
|
(598)
|
(3,189)
|
Total comprehensive income
|
-
|
-
|
-
|
2,515,962
|
(451,328)
|
2,064,634
|
|
80,312
|
2,144,946
|
Capital increase
|
96,062
|
(89,876)
|
-
|
-
|
-
|
6,186
|
|
-
|
6,186
|
Gains/(losses) of controlling interest´s share
(ii)
|
-
|
-
|
-
|
-
|
1,068,695
|
1,068,695
|
|
(1,079,050)
|
(10,355)
|
Dividends distributed
|
-
|
-
|
-
|
-
|
-
|
-
|
|
(30,876)
|
(30,876)
|
Purchase of shares and result on treasury shares
|
-
|
(2,548)
|
-
|
-
|
-
|
(2,548)
|
|
-
|
(2,548)
|
Share-based payments
|
-
|
33,473
|
-
|
-
|
-
|
33,473
|
|
-
|
33,473
|
Prescribed/(complement) dividends
|
-
|
-
|
-
|
(50)
|
-
|
(50)
|
|
-
|
(50)
|
At March 31, 2018
|
57,710,202
|
54,641,958
|
8,660,235
|
2,160,529
|
(74,349,103)
|
48,823,821
|
|
944,427
|
49,768,248
|
(i) As described in Note 3 -
Summary
of significant account policie.
(ii) As described in Note 1
-
Corporate information.
The accompanying notes are an integral part of these interim
consolidated financial statements.
Interim Consolidated Statements of Changes in Equity
(continued)
For the
three-month period ended March,31, 2018 and 2017
(Expressed in thousands of Brazilian Reais)
|
Attributable to equity holders of Ambev
|
|
|
|
|
Capital
|
Capital reserves
|
Net income reserves
|
Retained earnings
|
Carrying value adjustments
|
Total
|
|
Non-controlling interests
|
Total equity
|
At December 31, 2016
|
57,614,140
|
54,529,780
|
9,700,248
|
-
|
(77,019,120)
|
44,825,048
|
|
1,826,225
|
46,651,273
|
|
|
-
|
-
|
|
|
|
|
|
|
Net Income
|
-
|
-
|
-
|
2,199,135
|
-
|
2,199,135
|
|
90,696
|
2,289,831
|
|
|
|
|
|
|
|
|
|
|
Comprehensive income:
|
|
|
|
|
|
|
|
|
|
Gains/(losses) on translation of foreign operations
|
-
|
-
|
-
|
-
|
(440,798)
|
(440,798)
|
|
(42,009)
|
(482,807)
|
Cash flow hedges
|
-
|
-
|
-
|
-
|
107,231
|
107,231
|
|
(4)
|
107,227
|
Actuarial gain/(losses)
|
-
|
-
|
-
|
-
|
159,150
|
159,150
|
|
(23)
|
159,127
|
Total comprehensive income
|
-
|
-
|
-
|
2,199,135
|
(174,417)
|
2,024,718
|
|
48,660
|
2,073,378
|
Gains/(losses) of controlling interest´s share
|
-
|
-
|
-
|
-
|
(2,412)
|
(2,412)
|
|
371
|
(2,041)
|
Dividends distributed
|
-
|
-
|
-
|
-
|
-
|
-
|
|
(39,138)
|
(39,138)
|
Acquired shares and result on treasury shares
|
-
|
2,932
|
-
|
-
|
-
|
2,932
|
|
-
|
2,932
|
Share-based payment
|
-
|
(5,680)
|
-
|
-
|
-
|
(5,680)
|
|
-
|
(5,680)
|
Prescribed dividends
|
-
|
-
|
-
|
149
|
-
|
149
|
|
-
|
149
|
At March 31, 2017
|
57,614,140
|
54,527,032
|
9,700,248
|
2,199,284
|
(77,195,949)
|
46,844,755
|
|
1,836,118
|
48,680,873
|
The
accompanying notes are an integral part of these interim consolidated financial
statements.
Interim Consolidated Cash Flow Statements
For the three-month period ended March,31, 2018 and 2017
(Expressed in thousands of Brazilian Reais)
|
Note
|
03/31/2018
|
03/31/2017
|
|
|
|
|
Net income
|
|
2,597,629
|
2,289,831
|
Depreciation, amortization and impairment
|
|
869,095
|
827,570
|
Impairment losses on receivables and inventories
|
|
35,043
|
28,231
|
Additions/(reversals) in provisions and employee benefits
|
|
46,228
|
49,114
|
Net finance cost
|
17
|
544,293
|
872,595
|
Losses/(gain) on sale of property, plant and equipment and intangible assets
|
|
21,928
|
5,376
|
Equity-settled share-based payment expense
|
19
|
33,855
|
44,950
|
Income tax expense
|
18
|
619,863
|
338,513
|
Share of result of joint ventures
|
|
(617)
|
(1,032)
|
Other non-cash items included in the profit
|
|
(115,626)
|
123,473
|
Cash flow from operating activities before changes in working capital and use of provisions
|
|
4.651.691
|
4,578,621
|
|
|
|
|
(Increase)/decrease in trade and other receivables
|
|
865,500
|
1,438,315
|
(Increase)/decrease in inventories
|
|
(464,714)
|
(199,947)
|
Increase/(decrease) in trade and other payables
|
|
(2,509,576)
|
(2,707,944)
|
Cash generated from operations
|
|
2,542,901
|
3,109,045
|
|
|
|
|
Interest paid
|
|
(101,330)
|
(155,152)
|
Interest received
|
|
100,239
|
55,294
|
Dividends received
|
|
-
|
3,905
|
Income tax paid
|
|
(1,749,515)
|
(1,028,596)
|
Cash flow from operating activities
|
|
792,295
|
1,984,496
|
|
|
|
|
Proceeds from sale of property, plant and equipment and intangible assets
|
|
1,432
|
10,533
|
Acquisition of property, plant and equipment and intangible assets
|
|
(472,676)
|
(559,499)
|
Acquisition of subsidiaries, net of cash acquired
|
|
(3,074,047)
|
(332,730)
|
Acquisition of other investments
|
|
(5,000)
|
-
|
Investment in short term debt securities and net proceeds/(acquisition) of debt securities
|
|
(7,800)
|
272,555
|
Net proceeds/(acquisition) of other assets
|
|
(249)
|
1,558
|
Cash flow from investing activities
|
|
(3,558,340)
|
(607,583)
|
|
|
|
|
Capital increase
|
|
6,186
|
-
|
Proceeds/(repurchase) of treasury shares
|
|
(8,599)
|
(48,375)
|
Proceeds from borrowings
|
|
2,026,650
|
1,238,175
|
Repayment of borrowings
|
|
(93,437)
|
(1,482,810)
|
Cash net of finance costs other than interests
|
|
(307,307)
|
(429,861)
|
Payment of finance lease liabilities
|
|
(2,214)
|
(2,268)
|
Dividends and Interest on shareholder´s equity paid
|
|
(1,099,721)
|
(1,132,019)
|
Cash flow from financing activities
|
|
521,558
|
(1,857,158)
|
|
|
|
|
Net increase/(decrease) in cash and cash equivalents
|
|
(2,244,487)
|
(480,245)
|
Cash and cash equivalents less bank overdrafts at beginning of year
(i)
|
|
10,352,735
|
7,876,849
|
Effect of exchange rate fluctuations
|
|
(154,898)
|
(167,461)
|
Cash and cash equivalents less bank overdrafts at end of year
(i)
|
|
7,953,350
|
7,229,143
|
(i) Net of bank overdrafts.
The accompanying notes are an integral part of these interim
consolidated financial statements
.
Notes to the
interim consolidated financial statements:
1.
|
Corporate
information
|
2.
|
Statement
of compliance
|
3.
|
Summary
of significant accounting policies
|
4.
|
Use
of estimates and judgments
|
5.
|
Cash
and cash equivalents
|
6.
|
Investment
securities
|
7.
|
Inventories
|
8.
|
Deferred
income tax and social contribution
|
9.
|
Property,
plant and equipment
|
10.
|
Goodwill
|
11.
|
Interest-bearing
loans and borrowings
|
12.
|
Provisions
|
13.
|
Changes in
equity
|
14.
|
Segment
reporting
|
15.
|
Net Sales
|
16.
|
Other
operating income/(expenses)
|
17.
|
Finance cost
and income
|
18.
|
Income tax and
social contribution
|
19.
|
Share-based
payments
|
20.
|
Financial
instruments and risks
|
21.
|
Collateral and
contractual commitments, advances from customers and other
|
22.
|
Contingent liability
|
23.
|
Non-cash items
|
24.
|
Related
parties
|
25.
|
Events after
the reporting period
|
1.
CORPORATE INFORMATION
(a)
Description of business
Ambev S.A. (
referred to as the “Company” or “Ambev”),
headquartered in São Paulo, Brazil, produces and sells beer, draft beer, soft drinks, other non-alcoholic beverages, malt and food in general, as well as the advertising of its and third party products, the sale of promotional and advertising materials and the direct or indirect exploitation of bars, restaurants, snack bars and the like, among others.
The Company’s shares and ADR’s (American Depositary Receipts) are listed on the
B3 S.A.- Brasil, Bolsa, Balcão
as “ABEV3” and on the New York Stock Exchange (NYSE) as “ABEV”.
The Company’s direct controlling shareholders are Interbrew International B.V. (“IIBV”), AmBrew S.A. (“Ambrew”), both subsidiaries of Anheuser-Busch InBev N.V. (“AB InBev”) and Fundação Antonio e Helena Zerrenner Instituição Nacional de Beneficência (“Fundação Zerrenner”).
The interim financial statements
were approved by the Board of Directors on May 08, 2018.
(b)
Major corporate events in 2017 and 2018:
In January 2018, Ambev S.A., through its subsidiaries Labatt Breweries and Ambev Luxemburgo, acquired two new loans totaling approximately R$2.0 billion, maturing in up to one year.
Renegotiation of shareholders agreement CND
On December 1st, 2017, Ambev informed its shareholders and the general market that the E. León Jimenes, S.A. (“ELJ”), partner of Ambev in Tenedora CND, S.A. (“Tenedora”) – a holding company headquartered in Dominican Republic, which holds almost all shares of Cervecería Nacional Dominicana, S.A – would exercise partially, as provide for in shareholders’ agreement of Tenedora, ELJ put option of approximately 30% of capital stock by Tenedora. Due the partial put exercise option, the Company will pay to ELJ the amount of USD 926.5 million and would be the holder of approximately 85% of Tenedora, and ELJ will remain with 15% interest of CND. Considering the strategic importance of alliance with the ELJ, the Board of Directors of Ambev approved this date the change of the call option term from 2019 to 2022. The transaction was subject to certain conditions precedent that was concluded on January 18, 2018.
In January 18, 2018, Ambev S.A., informed its investors and the market in general that, as per the notice to the market issued as of December 1st, 2017, concluded the transaction with ELJ, shareholder in Tenedora, owner of almost the totality of CND. As a result of the such transaction, the Company, directly and indirectly, became the owner of approximately 85% of Tenedora, with ELJ owning the remaining 15%, as well as the term of exercise of the call option becomes from January 2019 to January 2022.
Adherence to the Special Tax Regularization Program
During the third quarter of 2017, the Company adhere a Special Program for Tax Regularization, fixed by Provisional Measure no. 783, from May 31, 2017, extended by the Provisional Measure no. 798 (“PERT in August, 30 2017”), undertaking to pay some tax
assessments
that were in dispute, including debts from its subsidiaries, for a total amount of R$3.5 billion, already considering discounts according to the program, having paid the amount of approximately R$960 million in 2017 and undertaking to pay the remaining value in 145 monthly installments, with interest, starting in January, 2018, the
installments owed until moment, have been paid.
Perpetual licensing agreement with Quilmes
In September 2017, AB InBev and Quilmes, a subsidiary of Ambev, entered into an agreement whereby AB InBev will grant a perpetual license to Quilmes in Argentina for Budweiser and other North American brands upon the recovery of the distribution rights by AB InBev from CCU. The agreement also foresees the transfer of the brewery of Cerveceria Argentina Sociedad Anonima Isenbeck by AB InBev to Quilmes and the transfer of some Argentinean brands (Norte, Iguana and Baltica) and related business assets along with US$50 millions by Quilmes to CCU. The closing of the transaction was subject to the approval of the Argentinean antitrust authority and others usual closing conditions. Additional information about the closing of this transaction are disclosed on Note 25 -
Events after the reporting period
.
Exchange contracts for future financial flows - Equity Swap
On May 16th, 2017, the Board of Directors of Ambev approved the execution, by and between the Company, or its subsidiaries, and financial institutions to be approved by the Board of Officers, of equity swaps, having as underlying asset the shares issued by the Company or American Depositary Receipts representing these shares (“ADRs”). The settlement of the equity swap will take place within a maximum period of 18 months from this date, and the agreements may cover an exposure of up to 80 million common shares, with a limit value of up to R$ 2.3 billion.
On December 21, 2017 Ambev's Board of Directors approved the conclusion of new equity swap contracts, without prejudice to the liquidation, within the regulatory term, of the contracts still in force. The new contracts may cover the exposure in up to 44 million common shares (of which all or part may be through ADR's), with a limit value of up to R$820 million, plus the balances of contracts executed in the context of the approval of May 16, 2017 and have not yet settled.
2.
STATEMENT OF COMPLIANCE
The consolidated financial statements have been prepared using the accounting basis of going concern and are being presented in accordance with IAS 34 - Interim Financial Reporting as issued by the International Accounting Standards Board (“IASB”).
The information does not meet all disclosure requirements for the presentation of full annual financial statements and thus should be read in conjunction with the consolidated financial statements prepared in accordance with International Financial Reporting Standards (“IFRS”) for the year ended December 31, 2017. To avoid duplication of disclosures which are included in the annual financial statements, the following notes were not subject to full filling:
(a)
Summary of significant accounting policies (Note 3);
(b)
Exceptional items (Note 8);
(c)
Payroll and related benefits (Note 9);
(d)
Additional information on operating expenses by nature (Note 10);
(e)
Intangible assets (Note 15);
(f)
Trade receivable (Note 19);
(g)
Changes in equity (Note 21);
(h)
Interest-bearing loans and borrowings (Note 22);
(i)
Employee benefits (Note 23);
(j)
Trade payables (Note 25);
(k)
Operating leases (Note 28);
(l)
Contingent liability
(Note 30);
(m)
Group Companies (Note 34);
(n)
Insurance (Note 35)
3.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
There were no significant changes in accounting policies and calculation methods used for the interim financial statements as of March 31, 2018 in relation to those presented in the financial statements for the year ended December 31, 2017, except for the polices described below:
IFRS 9 - Financial Instruments
replace IAS 39 for periods beginning on after 1
January 2018), introduces a logical approach for the classification of financial assets, which is driven by cash flow characteristics and the business model in which an asset is held; defines a new expected-loss impairment model that will require more effective recognition; and introduces a substantially-reformed model for hedge accounting, with enhanced disclosures about risk management activity. The new hedge accounting model represents a significant overhaul of the policies and aligns the accounting treatment with risk management activities. IFRS 9 also removes the volatility in profit or loss that was caused by changes in the credit risk of liabilities elected to be measured at fair value.
The company has applied IFRS 9 Financial Instruments as of the effective date, without restatement of the comparative information for the period beginning 1 January 2017. Consequently
,
the disclosures for the comparative periods follow the classification and measurement requirements under IAS 39. The company performed an impact assessment and concluded that IFRS 9 Financial Instruments does not impact materially its financial position, financial performance or risk management activities.
IFRS 15 -
Revenue from Contracts with Customers
requires revenue recognition to depict the transfer of goods or services to customers in amounts that reflect the consideration to which the Company expects to be entitled in exchange for those goods or services. The new standard
for periods beginning on after 1
January 2018 result in more and enhanced disclosures about revenue, provide guidance for transactions that were not previously addressed comprehensively (for example, service revenue and contract modifications) and improve guidance for
multiple-element arrangements.
The company has applied IFRS 15 Revenue from Contracts with Customers as of the effective date in accordance with the modified retrospective application. Under this approach, the cumulative effect of initially applying IFRS 15 must be recognized as an adjustment to the opening balance of equity at the date of initial application and comparative periods are not restated. On the implementation date, the adjustment to the opening balance of equity resulted in a decrease of the Retained earning by R$355,383, to reflect the changes in accounting policies related to performance that, in accordance whit the IFRS 15, should be related of the price transaction underlying r
evenue of 2017.
The other amendments to standards effective for annual periods beginning after 1 January 2018, have not been listed above because of either their non-applicability to or their immateriality to Ambev’s interim consolidated financial statements.
(a)
Basis of preparation and measurement
The interim financial statements are presented in
thousands
of Brazilian Real (“R$”),
unless otherwise indicated, rounded to the nearest
thousand
indicated
. Depending on the
applicable IFRS
requirement, the measurement basis used in preparing the interim financial
statements is historical cost, net realizable value, fair value or recoverable
amount.
(b)
Recently issued IFRS
The reporting standards below were published and are
mandatory
for future annual
reporting
periods
. Although IFRSs anticipate early adoption, in Brazil,
regulators have prevented this anticipation in order to preserve aspects of
comparability. Accordingly, for the period ended March 31, 2018, these
standards were not applied in the preparation of these financial statements:
IFRS 16 – Leases
(effective from annual periods beginning on or after 1
January 2019) replaces the existing lease accounting requirements and
represents a significant change in the accounting and reporting of leases that
were previously classified as operating leases, with more assets and
liabilities to be reported on the balance sheet and a different recognition of
lease costs.
The company is in process of assessing the full impact of IFRS 16 and
expects changes in the presentation of operating leases in the balance sheet.
Other Standards, Interpretations and Amendments to Standards
The other amendments to standards effective for annual periods beginning
after 1 January 2018, have not been listed above because of either their
non-applicability to or their immateriality to Ambev’s consolidated financial
statements.
4.
USE
OF ESTIMATES AND JUDGMENTS
The preparation of interim
financial statements in conformity with IFRS requires Management to make
judgments, estimates and assumptions that affect the application of accounting practices
and the reported amounts of assets and liabilities, income and expenses. The
estimates and associated assumptions are based on past experience and various
other factors that are believed to be reasonable under the circumstances, the
results of which form the basis for decision making regarding the judgments
about carrying amounts of assets and liabilities that are not readily evident
from other sources. Actual results may differ from these estimates.
The estimates and
assumptions are reviewed on a regular basis. Changes in accounting estimates
may affect the period in which they are realized, or future periods.
Although each of its
significant accounting policies reflects judgments, assessments or estimates,
the Company believes that the following accounting practices reflect the most
critical judgments, estimates and assumptions that are important to its
business operations and the understanding of its results:
(i) predecessor
basis of accounting;
(ii) business combinations;
(iii) impairment;
(iv) provisions;
(v) share-based payments;
(vi) employee benefits;
(vii) current and deferred tax;
(viii) joint arrangements; e
(ix) measurement of financial instruments, including
derivatives.
The
fair values of acquired identifiable intangibles are based on an assessment of
future cash flows. Impairment analyses of goodwill and indefinite-lived
intangible assets are performed at least annually and whenever a triggering
event occurs, in order to determine whether the carrying value exceeds the
recoverable amount.
The
company uses its judgment to select a variety of methods including the
discounted cash flow method and option valuation models and makes assumptions
about the fair value of financial instruments that are mainly based on market
conditions existing at each balance sheet date.
Actuarial
assumptions are established to anticipate future events and are used in
calculating pension and other long-term employee benefit expense and liability.
These factors include assumptions with respect to interest rates, rates of
increase in health care costs, rates of future compensation increases, turnover
rates, and life expectancy.
The
company is subject to income tax in numerous jurisdictions. Significant
judgment is required in determining the worldwide provision for income tax.
There are some transactions and calculations for which the ultimate tax
determination is uncertain. Some subsidiaries within the Company are involved
in tax audits usually in relation to prior years. These audits are ongoing in
various jurisdictions at the balance sheet date and, by their nature, these can
take considerable time until its conclusion.
5.
CASH
AND CASH EQUIVALENTS
|
03/31/2018
|
12/31/2017
|
|
|
|
Cash
|
242,861
|
588,900
|
Current bank accounts
|
3,939,239
|
5,077,083
|
Short term bank deposits
(i)
|
3,771,377
|
4,688,544
|
Cash and cash equivalents
|
7,953,477
|
10,354,527
|
|
|
|
Bank overdrafts
|
(127)
|
(1,792)
|
Cash and cash equivalents less bank overdraft
|
7,953,350
|
10,352,735
|
(i) The balance refers mostly to Bank Deposit
Certificates - CDB, high liquidity, which are readily convertible into known
amounts of cash and which are subject to an insignificant risk of change in
value.
6.
INVESTMENTS
SECURITIES
|
03/31/2018
|
12/31/2017
|
|
|
|
Financial asset at fair value through profit or
loss-held for trading
|
12,229
|
11,883
|
Current investments securities
|
12,229
|
11,883
|
|
|
|
Debt held-to-maturity
(i)
|
143,481
|
121,956
|
Non-current investments securities
|
143,481
|
121,956
|
|
|
|
Total
|
155,710
|
133,839
|
(i) The balance
refers substantially to Bank Deposit Certificates - CDB linked to tax
incentives.
7.
INVENTORIES
|
03/31/2018
|
12/31/2017
|
|
|
|
Finished goods
|
1,708,958
|
1,528,434
|
Work in progress
|
306,187
|
309,567
|
Raw material
|
2,028,556
|
1,816,331
|
Consumables
|
94,348
|
77,208
|
Spare parts and other
|
479,933
|
476,924
|
Prepayments
|
205,130
|
210,861
|
Impairment losses
|
(97,995)
|
(100,352)
|
|
4,725,117
|
4,318,973
|
Write-offs/losses on inventories recognized in the
income statement amounted to
R$22,292 in the period
ended in March 31,
2018 (R$11,430
in the period ended in March 31,
2017).
8.
DEFERRED
INCOME TAX AND SOCIAL CONTRIBUTION
Deferred
taxes for income tax and social contribution taxes are calculated on tax
losses, the negative tax basis of social contributions and the temporary
differences between the tax bases and the carrying amount in the interim financial
statement of assets and liabilities. The rates of these taxes in Brazil, which
are expected at the realization of deferred taxes, are 25% for income tax and
9% for social contribution. For the other regions, with operational activity, expected
rates, are as follow:
Central
America and the Caribbean
|
from 23% to
31%
|
Latin
America
(i)
|
from 14% to
35%
|
Canada
|
26%
|
(i)
Amendments to Argentine tax legislation approved on December 29, 2017 affect
tax periods beginning in October 2018 and reduce the income tax rate in the
first two years from 35% to 30% and, as a after, to 25%.
Deferred tax assets are recognized to the extent that it
is probable that future taxable profit will be available to be used to offset
temporary differences / loss carry forwards based on projections of future
results prepared and based on internal assumptions and future economic
scenarios which may therefore change.
The amount of deferred income tax and social
contribution by type of temporary difference is detailed as follows:
|
03/31/2018
|
|
12/31/2017
|
|
Assets
|
Liabilities
|
Net
|
|
Assets
|
Liabilities
|
Net
|
Investment securities
|
115,012
|
-
|
115,012
|
|
39,028
|
-
|
39,028
|
Intangible
|
-
|
(713,459)
|
(713,459)
|
|
-
|
(719,481)
|
(719,481)
|
Employee benefits
|
528,898
|
-
|
528,898
|
|
631,067
|
-
|
631,067
|
Trade payables
|
1,272,675
|
(297,771)
|
974,904
|
|
1,382,378
|
(314,154)
|
1,068,224
|
Trade receivable
|
47,887
|
-
|
47,887
|
|
52,256
|
-
|
52,256
|
Derivatives
|
708
|
(13,063)
|
(12,355)
|
|
6,816
|
(5,849)
|
967
|
Inventories
|
202,368
|
(10,265)
|
192,103
|
|
248,731
|
(18,123)
|
230,608
|
Property, plant and equipment
|
-
|
(928,666)
|
(928,666)
|
|
-
|
(920,475)
|
(920,475)
|
Withholding tax over undistributed profits and
royalties
|
-
|
(770,383)
|
(770,383)
|
|
-
|
(788,594)
|
(788,594)
|
Investments in associates
|
-
|
(421,589)
|
(421,589)
|
|
-
|
(421,589)
|
(421,589)
|
Interest on shareholders' equity
|
299,655
|
-
|
299,655
|
|
-
|
-
|
-
|
Loss carryforwards
|
441,063
|
-
|
441,063
|
|
500,952
|
-
|
500,952
|
Provisions
|
329,850
|
(46,997)
|
282,853
|
|
347,337
|
(39,698)
|
307,639
|
Complement of income tax of foreign subsidiaries due
in Brazil
|
-
|
(9,470)
|
(9,470)
|
|
-
|
-
|
-
|
Other items
|
-
|
(55,843)
|
(55,843)
|
|
-
|
(30,492)
|
(30,492)
|
Gross deferred tax assets / (liabilities)
|
3,238,116
|
(3,267,506)
|
(29,390)
|
|
3,208,565
|
(3,258,455)
|
(49,890)
|
Netting by taxable entity
|
(889,535)
|
889,535
|
-
|
|
(929,226)
|
929,226
|
-
|
Net deferred tax assets / (liabilities)
|
2,348,581
|
(2,377,971)
|
(29,390)
|
|
2,279,339
|
(2,329,229)
|
(49,890)
|
The Company only offsets the balances of deferred income
tax and social contribution assets against liabilities when they are within the
same entity and are expected to be realized in the same period.
Tax losses and negative bases of social contribution and
temporary deductible differences in Brazil, on which the deferred income tax
and social contribution were calculated, have no expiry date.
At March 31,
2018 the assets and liabilities deferred taxes related to combined tax losses
has an expected utilization/settlement by temporary differences as follows:
|
03/31/2018
|
Deferred taxes not related to tax losses
|
to be realized until 12 months
|
to be realized after 12 months
|
Total
|
|
|
|
|
Investment securities
|
-
|
115,012
|
115,012
|
Intangible
|
-
|
(713,459)
|
(713,459)
|
Employee benefits
|
20,338
|
508,560
|
528,898
|
Trade payables
|
1,272,675
|
(297,771)
|
974,904
|
Trade receivable
|
40,772
|
7,115
|
47,887
|
Derivatives
|
(12,355)
|
-
|
(12,355)
|
Inventories
|
192,103
|
-
|
192,103
|
Property, plant and equipment
|
(54,308)
|
(874,358)
|
(928,666)
|
Withholding tax over undistributed profits and
royalties
|
-
|
(770,383)
|
(770,383)
|
Investments in associates
|
-
|
(421,589)
|
(421,589)
|
Interest on shareholders' equity
|
299,655
|
-
|
299,655
|
Provisions
|
70,320
|
212,533
|
282,853
|
Complement of income tax of foreign subsidiaries due
in Brazil
|
(9,470)
|
-
|
(9,470)
|
Other items
|
-
|
(55,843)
|
(55,843)
|
Total
|
1,819,730
|
(2,290,183)
|
(470,453)
|
Deferred tax related to tax losses
|
03/31/2018
|
2018
|
162,949
|
2019
|
98,332
|
2020
|
16,111
|
2021
|
10,608
|
Apart from 2022
(i)
|
153,063
|
Total
|
441,063
|
(i) There is no expectation of realization that exceeds the term of 10
years.
At
March 31, 2018, deferred tax assets in the amount of R$441,150 (R$427,365 in December
31, 2017) related to tax losses and temporary differences of subsidiaries abroad
were not recorded as the realization is not probable.
Major
part of the deferred asset amount do not have carryforward limit for
utilization and the tax losses carried forward in relation to them are
equivalent to R$1,764,599 in March 31, 2018 (R$1,709,461 in December 31, 2017).
The
net change in deferred income tax and social contribution is detailed as
follows:
At December 31, 2017
|
(49,890)
|
Investment hedge - put option of a subsidiary interest
|
(29,565)
|
Cash flow hedge - gains/(losses)
|
29,223
|
Gains/(losses) on translation of other foreign
operations
|
(88,733)
|
Recognized in other comprehensive income
|
(89,075)
|
Recognized in income statement
|
108,190
|
Changes directly in balance sheet
|
1,385
|
Recognized in other group of balance sheet
|
1,385
|
At March 31, 2018
|
(29,390)
|
9.
PROPERTY,
PLANT AND EQUIPMENT
|
03/31/2018
|
|
12/31/2017
|
|
Land and buildings
|
Plant and equipment
|
Fixtures and fittings
|
Under construction
|
Total
|
|
Total
|
Acquisition cost
|
|
|
|
|
|
|
|
Balance at end of previous year
|
8,961,829
|
24,538,753
|
5,076,403
|
1,257,962
|
39,834,947
|
|
37,419,363
|
Effect of movements in foreign exchange
|
(29,078)
|
(141,055)
|
(50,131)
|
(18,531)
|
(238,795)
|
|
18,628
|
Business combinations
|
-
|
-
|
-
|
-
|
-
|
|
204,189
|
Acquisitions
|
598
|
143,755
|
29,740
|
298,550
|
472,643
|
|
3,175,486
|
Disposals
|
(510)
|
(171,167)
|
(138,021)
|
(39)
|
(309,737)
|
|
(706,845)
|
Transfer to other asset categories
|
52,201
|
139,925
|
95,051
|
(399,965)
|
(112,788)
|
|
(310,910)
|
Others
|
-
|
6,556
|
-
|
-
|
6,556
|
|
35,036
|
Balance at end
|
8,985,040
|
24,516,767
|
5,013,042
|
1,137,977
|
39,652,826
|
|
39,834,947
|
|
|
|
|
|
|
|
|
Depreciation and Impairment
|
|
|
|
|
|
|
|
Balance at end of previous year
|
(2,585,748)
|
(14,973,468)
|
(3,453,404)
|
-
|
(21,012,620)
|
|
(18,265,527)
|
Effect of movements in foreign exchange
|
5,565
|
61,311
|
32,246
|
-
|
99,122
|
|
(116,585)
|
Depreciation
|
(77,102)
|
(545,258)
|
(163,978)
|
-
|
(786,338)
|
|
(3,200,379)
|
Impairment losses
|
-
|
(29,578)
|
(36)
|
-
|
(29,614)
|
|
(125,185)
|
Disposals and write-off
|
183
|
150,381
|
136,061
|
-
|
286,625
|
|
654,320
|
Transfer to other asset categories
|
1,739
|
50,097
|
12,056
|
-
|
63,892
|
|
32,899
|
Others
|
-
|
2,417
|
-
|
-
|
2,417
|
|
7,837
|
Balance at end
|
(2,655,363)
|
(15,284,098)
|
(3,437,055)
|
-
|
(21,376,516)
|
|
(21,012,620)
|
Carrying amount:
|
|
|
|
|
|
|
|
December 31, 2017
|
6,376,081
|
9,565,285
|
1,622,999
|
1,257,962
|
18,822,327
|
|
18,822,327
|
March 31, 2018
|
6,329,677
|
9,232,669
|
1,575,987
|
1,137,977
|
18,276,310
|
|
-
|
Leases,
capitalizes interests and fixed assets provided as security are not material.
10.
GOODWILL
|
03/31/2018
|
12/31/2017
|
|
|
|
Balance at end of previous year
|
31,401,874
|
30,511,200
|
Effect of movements in foreign exchange
|
(210,128)
|
489,689
|
Acquisition and disposal through business combinations
(i)
|
-
|
400,985
|
Balance at the end of year
|
31,191,746
|
31,401,874
|
The
carrying amount of goodwill was allocated to the different cash-generating
units as follows
:
|
Functional currency
|
03/31/2018
|
12/31/2017
|
LAN:
|
|
|
|
Brazil
|
BRL
|
17,668,393
|
17,668,393
|
Goodwill
|
|
102,911,026
|
102,911,026
|
Non-controlling transactions (i)
|
|
(85,242,633)
|
(85,242,633)
|
Dominican Republic
|
DOP
|
3,111,127
|
3,163,679
|
Cuba
(ii)
|
USD
|
2,357
|
2,672
|
Panama
|
PAB
|
1,154,821
|
1,149,332
|
|
|
|
|
LAS:
|
|
|
|
Argentina
|
ARS
|
415,632
|
443,826
|
Bolivia
|
BOB
|
1,175,694
|
1,170,108
|
Chile
|
CLP
|
47,987
|
47,007
|
Paraguay
|
PYG
|
800,466
|
786,071
|
Uruguay
|
UYU
|
173,847
|
170,675
|
|
|
|
|
NA:
|
|
|
|
Canada
|
CAD
|
6,641,422
|
6,800,111
|
|
|
31,191,746
|
31,401,874
|
(i) It refers to
the exchange of shareholdings operation occurred in 2013 as a result of the
adoption of the predecessor basis of accounting.
(ii) The
functional currency of Cuba, the Cuban convertible peso (CUC), has fixed parity
with the dollar (USD) at balance sheet date.
11.
INTEREST-BEARING
LOANS AND BORROWINGS
|
03/31/2018
|
12/31/2017
|
|
|
|
Secured bank loans
|
2,860,851
|
879,638
|
Unsecured bank loans
|
374,127
|
394,267
|
Other unsecured loans
|
36,136
|
38,423
|
Financial leasing
|
7,785
|
8,794
|
Current liabilities
|
3,278,899
|
1,321,122
|
|
|
|
Secured bank loans
|
571,965
|
589,237
|
Unsecured bank loans
|
380,564
|
413,749
|
Debentures and unsecured bond issues
|
103,223
|
102,739
|
Other unsecured loans
|
109,442
|
101,509
|
Financial leasing
|
23,562
|
24,694
|
Non-current liabilities
|
1,188,756
|
1,231,928
|
Additional information regarding the exposure of the
Company to the risks of interest rate and foreign currency are disclosed on
Note 20 –
Financial instruments and risks
.
Contractual
clauses (covenants)
As at March 31, 2018, the
Company's loans had equal rights to payment without subordination clauses.
Except for the credit lines due to FINAME contracted by the Company with Banco
Nacional de Desenvolvimento Econômico e Social – BNDES (“BNDES”), where
collateral were provided on assets acquired with the credit granted which
serve as collateral; other loans and financing contracted by the Company predicted
only guarantees as personal collateral or are unsecured. The most loan contracts contained financial covenants including: financial covenants, including limitation on new indebtedness; going-concern; maintenance, in use or in good condition for the business, of the Company's assets; restrictions on acquisitions, mergers, sale or disposal of its assets; disclosure of financial statements under Brazilian GAAP and IFRS; and/or no prohibition related to new real guarantees for loans contracted, except if: (i) expressly authorized under the aforementioned loan agreement, (ii) new loans contracted from financial institutions linked to the Brazilian government - including the BNDES or foreign governments; - or foreign governments, multilateral financial institutions (eg World Bank) or located in jurisdictions in which the Company operates.
As at March 31, 2018, the Company was in compliance with all its contractual obligations for its loans and financings.
12.
PROVISIONS
(a) Provision changes
|
Balance as of December 31, 2017
|
Effect of changes in foreign exchange rates
|
Additions
|
Provisions used and reversed
|
Balance as of March 31, 2018
|
|
|
|
|
|
|
Restructuring
|
8,099
|
(166)
|
-
|
(23)
|
7,910
|
|
|
|
|
|
|
Provision for disputes and litigations
|
|
|
|
|
-
|
Taxes on sales
|
226,268
|
(234)
|
8,481
|
(5,527)
|
228,988
|
Income tax
|
157,011
|
108
|
2,927
|
(10)
|
160,036
|
Labor
|
129,396
|
(945)
|
36,873
|
(53,462)
|
111,862
|
Civil
|
35,273
|
47
|
18,055
|
(8,512)
|
44,863
|
Others
|
125,490
|
(2,091)
|
12,440
|
(30,612)
|
105,227
|
Total of provision for disputes and litigations
|
673,438
|
(3,115)
|
78,776
|
(98,123)
|
650,976
|
|
|
|
|
|
|
Total provisions
|
681,537
|
(3,281)
|
78,776
|
(98,146)
|
658,886
|
(b)
Disbursement expectative
|
Balance as of March 31, 2018
|
1 year or less
|
1-2 years
|
2-5 years
|
Over 5 years
|
|
|
|
|
|
|
Restructuring
|
7,910
|
7,119
|
-
|
791
|
-
|
|
|
|
|
|
|
Provision for disputes and litigations
|
|
|
|
|
|
Taxes on sales
|
228,988
|
25,717
|
182,256
|
5,078
|
15,937
|
Income tax
|
160,036
|
33,592
|
103,189
|
23,255
|
-
|
Labor
|
111,862
|
77,278
|
16,726
|
11,703
|
6,155
|
Civil
|
44,863
|
17,105
|
23,593
|
2,443
|
1,722
|
Others
|
105,227
|
7,920
|
25,076
|
69,419
|
2,812
|
Total of provision for disputes and litigations
|
650,976
|
161,612
|
350,840
|
111,898
|
26,626
|
|
|
|
|
|
|
Total provisions
|
658,886
|
168,731
|
350,840
|
112,689
|
26,626
|
The expected settlement of provisions was based on management’s best estimate at the interim balance sheet date.
Main lawsuits with probable likelihood of loss:
(a) Income and Sales taxes
In Brazil, the Company and its subsidiaries are involved in several administrative and judicial proceedings related to Income tax, ICMS, IPI, PIS and COFINS taxes. Such proceedings include, among others, tax offsets, credits and judicial injunctions exempting tax payment.
(b) Labor
The Company and its subsidiaries are involved in labor proceedings with former employees or former employees of service providers. The main issues involve overtime and related effects and respective charges.
(c) Civil
The Company is involved in civil lawsuits considered with probable likelihood of loss. The most relevant portion of these lawsuits refers to former distributors, mainly in Brazil, which are mostly claiming damages resulting from the termination of their contracts.
The processes with possible probabilities are disclosed in Note 22
-
Contingent liability
.
13.
CHANGES IN EQUITY
(a) Capital stock
|
|
03/31/2018
|
|
|
12/31/2017
|
|
Thousands of common shares
|
Thousands of Real
|
|
Thousands of common shares
|
Thousands of Real
|
Beginning balance as per statutory books
|
15,717,615
|
57,614,140
|
|
15,717,615
|
57,614,140
|
Share issued
|
4,532
|
96,062
|
|
-
|
-
|
|
15,722,147
|
57,710,202
|
|
15,717,615
|
57,614,140
|
(b)
Capital reserves
|
Capital Reserves
|
|
|
Treasury shares
|
Share Premium
|
Others capital reserves
|
Share-based Payments
|
Total
|
|
|
|
|
|
|
At December 31, 2017
|
(894,994)
|
53,662,811
|
700,898
|
1,232,194
|
54,700,909
|
Capital Increase
|
-
|
-
|
-
|
(89,876)
|
(89,876)
|
Purchase of shares and result on treasury shares
|
(2,548)
|
-
|
-
|
-
|
(2,548)
|
Share-based payments
|
-
|
-
|
-
|
33,473
|
33,473
|
At March 31, 2018
|
(897,542)
|
53,662,811
|
700,898
|
1,175,791
|
54,641,958
|
|
Capital Reserves
|
|
|
Treasury shares
|
Share Premium
|
Others capital reserves
|
Share-based Payments
|
Total
|
At December 31, 2016
|
(908,676)
|
53,662,811
|
700,898
|
1,074,747
|
54,529,780
|
Purchase of shares and result on treasury
shares
|
2,932
|
-
|
-
|
-
|
2,932
|
Share-based payments
|
-
|
-
|
-
|
(5,680)
|
(5,680)
|
At March 31, 2017
|
(905,744)
|
53,662,811
|
700,898
|
1,069,067
|
54,527,032
|
(b.1) Treasury shares
The treasury shares comprise own issued shares
reacquired by the Company and the result on treasury shares that refers to
gains and losses related to share-based payments transactions and others.
Follows the changes of treasury shares:
|
Purchase /realization shares
|
|
Result on Treasure Shares
|
|
Total Treasure Shares
|
|
Thousands shares
|
|
Thousands Brazilian Real
|
|
Thousands shares
|
|
Thousands Brazilian Real
|
|
|
|
|
At December 31, 2017
|
7,394
|
|
(139,665)
|
|
(755,329)
|
|
(894,994)
|
Changes during the year
|
(2,596)
|
|
41,796
|
|
(44,344)
|
|
(2,548)
|
At March 31, 2018
|
4,798
|
|
(97,869)
|
|
(799,673)
|
|
(897,542)
|
|
Purchase /realization shares
|
|
Result on Treasure Shares
|
|
Total Treasure Shares
|
|
Thousands shares
|
|
Thousands Brazilian Real
|
|
Thousands shares
|
|
Thousands Brazilian Real
|
|
|
|
|
|
|
|
|
|
|
|
|
At December 31, 2016
|
16,512
|
|
(312,670)
|
|
(596,006)
|
|
(908,676)
|
Changes during the year
|
(1,798)
|
|
40,306
|
|
(37,374)
|
|
2,932
|
At March 31, 2017
|
14,714
|
|
(272,364)
|
|
(633,380)
|
|
(905,744)
|
(b.2)
Share premium
The share premium refers to the difference between
subscription price that the shareholders paid for the shares and theirs nominal
value. Since this is a capital reserve, it can only be used to increase
capital, offset losses, redemptions, reimbursement or repurchase shares.
(b.3) Share-based payment
There are different share-based payment programs and
stock option plans which allow the senior management from Ambev economic group
to receive or acquire shares of the Company.
The share-based payment
reserve recorded a charge of
R$33,855 at March 31,
2018
(
R$44,950
at March 31, 2017
) (Note 19 –
Share-based
payments
).
(c)
Net
income reserves
|
Net income reserves
|
|
Investments reserve
|
Statutory reserve
|
Fiscal incentive
|
Interest on capital and dividends proposed
|
Total
|
At December 31, 2017
|
1,267,721
|
4,456
|
7,388,058
|
-
|
8,660,235
|
|
|
|
|
|
|
At March 31, 2018
|
1,267,721
|
4,456
|
7,388,058
|
-
|
8,660,235
|
|
Net income reserves
|
|
Investments reserve
|
Statutory reserve
|
Fiscal incentive
|
Interest on capital and dividends proposed
|
Total
|
At December 31, 2016
|
3,859,995
|
4,456
|
5,835,797
|
-
|
9,700,248
|
|
|
|
|
|
|
At March 31, 2017
|
3,859,995
|
4,456
|
5,835,797
|
-
|
9,700,248
|
(c.1) Investments reserve
From net income after deductions applicable, will be aimed
no more than 60% (sixty per cent) to investment reserve to support future
investments.
(c.2) Statutory reserve
From net income, 5% will be applied before any other allocation,
to the statutory reserve, which cannot exceed 20% of capital stock. The Company
is not required to supplement the statutory reserve in the year when the
balance of this reserve, plus the amount of capital reserves, exceeds 30% of
the capital stock.
(c.3) Tax incentives
The Company has tax incentives framed in certain state and
federal industrial development programs in the form of financing, deferred
payment of taxes or partial reductions of the amount due. These state programs
aim to promote the expansion of employment generation, regional
decentralization, complement and diversify the industrial base of the States.
In these states, the grace periods, enjoyment and reductions are permitted
under the tax law.
The portion of income for the period
related to tax incentives, which will be allocated to the profit reserve at the
end of the fiscal year on December 31, 2018 and therefore not being used as a
basis for dividend distribution, is composed of:
|
03/31/2018
|
03/31/2017
|
ICMS (Brazilian State value added)
|
413,734
|
434,413
|
Income tax
|
53,460
|
28,141
|
|
467,194
|
462,554
|
(c.4) Interest on shareholders’ equity / Dividends
Brazilian
companies are permitted to distribute interest attributed to shareholders’
equity calculated based on the long-term interest rate (TJLP), such interest
being tax-deductible, in accordance with the applicable law and, when
distributed, may be considered part of the minimum mandatory dividends.
As determined by its By-laws, the Company is required to
distribute to its shareholders, as a minimum mandatory dividend in respect of
each fiscal year ending on December 31,an amount not less than 40% of its net
income determined under Brazilian law, as adjusted in accordance with applicable
law, unless payment of such amount would be incompatible with Ambev’s financial
situation. The minimum mandatory dividend includes amounts paid as interest on
shareholders’ equity.
There was no allocation
of dividends or interest on shareholders' equity in the three-month period
ended March 31, 2017 and 2018.
(d) Carrying
value adjustments
|
Carrying value adjustments
|
|
|
Translation reserves
|
Cash flow hedge
|
Actuarial gains/ (losses)
|
Options granted on subsidiary
|
Gains/(losses) of non-controlling
interest´s share
|
Business combination
|
Accounting adjustments for
transactions between shareholders
|
Total
|
At December 31, 2017
|
1,639,099
|
368,806
|
(1,144,468)
|
(2,771,248)
|
2,099,921
|
156,091
|
(75,314,671)
|
(74,966,470)
|
Comprehensive income:
|
|
|
|
|
|
|
|
|
Gains/(losses) on translation of foreign operations
|
(392,994)
|
-
|
-
|
-
|
-
|
-
|
-
|
(392,994)
|
Cash flow hedges
|
-
|
(55,743)
|
-
|
-
|
-
|
-
|
-
|
(55,743)
|
Actuarial gains/(losses)
|
-
|
-
|
(2,591)
|
-
|
-
|
-
|
-
|
(2,591)
|
Total Comprehensive income
|
(392,994)
|
(55,743)
|
(2,591)
|
-
|
-
|
-
|
-
|
(451,328)
|
Gains/(losses) of controlling interest´s share
(i)
|
460,105
|
787
|
3,540
|
2,650,465
|
(2,046,202)
|
-
|
-
|
1,068,695
|
At March 31, 2018
|
1,706,210
|
313,850
|
(1,143,519)
|
(120,783)
|
53,719
|
156,091
|
(75,314,671)
|
(74,349,103)
|
|
Carrying value adjustments
|
|
|
Translation reserves
|
Cash flow hedge
|
Actuarial gains/ (losses)
|
Options granted on subsidiary
|
Gains/(losses) of non-controlling interest´s share
|
Business combination
|
Accounting adjustments for transactions between shareholders
|
Total
|
At December 31, 2016
|
(289,483)
|
(144,568)
|
(1,262,170)
|
(2,390,843)
|
2,150,643
|
156,091
|
(75,238,790)
|
(77,019,120)
|
Comprehensive income:
|
|
|
|
|
|
|
|
|
Gains/
(losses) on translation
of foreign operations
|
(440,798)
|
-
|
-
|
-
|
-
|
-
|
-
|
(440,798)
|
Cash flow hedges
|
-
|
107,231
|
-
|
-
|
-
|
-
|
-
|
107,231
|
Actuarial gains/(losses)
|
-
|
-
|
159,150
|
-
|
-
|
-
|
-
|
159,150
|
Total Comprehensive income
|
(440,798)
|
107,231
|
159,150
|
-
|
-
|
-
|
-
|
(174,417)
|
Gains/(losses) of controlling interest´s share
|
-
|
-
|
-
|
-
|
(2,412)
|
-
|
-
|
(2,412)
|
At March 31, 2017
|
(730,281)
|
(37,337)
|
(1,103,020)
|
(2,390,843)
|
2,148,231
|
156,091
|
(75,238,790)
|
(77,195,949)
|
(i) As described in Note 1
-
Corporate
information
(d.1) Translation reserves
The translation reserves comprise all foreign currency exchange differences arising from the translation of the interim financial statements with functional currency different from the Real.
The translation reserves also comprise the portion of the gain or loss on the foreign currency liabilities and on the derivative financial instruments determined to be effective net investment hedges in conformity with IAS 39.
(d.2) Cash flow hedge reserves
The hedging reserves comprise the effective portion of the cumulative net change in the fair value of cash flow hedges to the extent the hedged risk has not yet impacted profit or loss (For additional information, see Note 20 –
Financial instruments and risks)
.
(d.3) Actuarial gains and losses
The actuarial gains and losses include expectations with regards to the future pension plans obligations. Consequently, the results of actuarial gains and losses are recognized on timely basis considering best estimate obtained by Management. Accordingly, the Company recognizes on monthly basis the results of these estimated actuarial gains and losses according to the expectations presented based on an independent actuarial report.
The actuarial gain of R$158,509 in 2017 arising from the surplus reverted to the Sponsor, originating from Ambev Private Pension Institute of the defined benefits plan was fully recorded under the heading of actuarial gains and losses in equity.
(d.4) O
ptions
granted on
subsidiary
As part of the shareholders agreement between the Ambev and ELJ, an option to sell (“put”) and to purchase (“call”) was issued, which may result in an acquisition by Ambev of the remaining shares of Tenedora CND, for a value based on EBITDA, +/- net debt, from operations. As disclosed in Note 1, on December 1st, 2017, the E. León Jimenes, S.A. (“ELJ”) will exercise partially its put option of approximately 30% of capital stock by Tenedora. Due to the partial exercise of put option, the Company
became the owner of approximately 85% of Tenedora. Additionally, was approved the change of the call option term from 2019 to 2022.
On March 31, 2018 the put option held by ELJ is valued at R$1,974,326 (R$5,520,155 on December 31, 2017) and the liability categorized as “Level 3”, as the Note 20 (b) and in accordance with the IFRS 3. No value has been assigned to the call option held by the Company, since the likelihood of exercise is remote. The fair value of this consideration deferred was calculated by using standard valuation techniques (present value of the principal amount and future interest rates, discounted by the market rate). The criteria used are based on
market information and from reliable sources and the fair value is revaluated on an annual basis.
As part of the agreement to acquire the shares of Sucos do Bem, a put option on minority shareholders' participation determined by gross revenue of its products and exercisable from 2019 has been granted, with a few exceptions. On March 31, 2018 the option is valued at R$132,895 (R$131,980 on December 31, 2017).
The reconciliation of changes in these options is presented in Note 20
– Financial instruments and risks
.
(d.5) Accounting for acquisition of non-controlling interests
In transactions with non-controlling interests of the same business, even when performed at arm's length terms, that present valid economic grounds and reflect normal market conditions, will be consolidated by the applicable accounting standards as occurred within the same accounting entity.
As determined by IFRS 10, any difference between the amount paid (fair value) for the acquisition of non-controlling interests and are related to carrying amount of such non-controlling interest shall be recognized directly in controlling shareholders’ equity. The acquisition of non-controlling interest related to Old Ambev, the above mentioned adjustment was recognized in the Carrying value adjustments when applicable.
14.
SEGMENT REPORTING
(a)
Reportable segments – three-month periods ended in:
|
Latin America - north
(i)
|
Latin America - south
(ii)
|
Canada
|
Consolidated
|
|
03/31/2018
|
03/31/2017
|
03/31/2018
|
03/31/2017
|
03/31/2018
|
03/31/2017
|
03/31/2018
|
03/31/2017
|
|
|
|
|
|
|
|
|
|
Net sales
|
7,330,154
|
7,352,066
|
3,091,535
|
2,763,989
|
1,218,530
|
1,125,750
|
11,640,219
|
11,241,805
|
Cost of sales
|
(2,837,794)
|
(3,128,417)
|
(1,168,877)
|
(1,059,907)
|
(454,077)
|
(334,817)
|
(4,460,748)
|
(4,523,141)
|
Gross profit
|
4,492,360
|
4,223,649
|
1,922,658
|
1,704,082
|
764,453
|
790,933
|
7,179,471
|
6,718,664
|
Distribution expenses
|
(1,076,612)
|
(1,032,054)
|
(298,474)
|
(258,272)
|
(248,732)
|
(221,118)
|
(1,623,818)
|
(1,511,444)
|
Sales and marketing expenses
|
(920,241)
|
(917,350)
|
(325,653)
|
(302,633)
|
(225,576)
|
(193,803)
|
(1,471,470)
|
(1,413,786)
|
Administrative expenses
|
(384,688)
|
(376,650)
|
(121,996)
|
(97,431)
|
(65,459)
|
(81,578)
|
(572,143)
|
(555,659)
|
Other operating income/(expenses)
|
277,409
|
288,233
|
(13,377)
|
1,438
|
(6,472)
|
1,155
|
257,560
|
290,826
|
Exceptional items
|
(2,283)
|
(16,159)
|
(6,149)
|
(12,535)
|
-
|
-
|
(8,432)
|
(28,694)
|
Income from operations (EBIT)
|
2,385,945
|
2,169,669
|
1,157,009
|
1,034,649
|
218,214
|
295,589
|
3,761,168
|
3,499,907
|
Net finance cost
|
(233,279)
|
(694,062)
|
(284,627)
|
(156,154)
|
(26,387)
|
(22,379)
|
(544,293)
|
(872,595)
|
Share of result of joint ventures
|
290
|
694
|
-
|
-
|
327
|
338
|
617
|
1,032
|
Income before income tax
|
2,152,956
|
1,476,301
|
872,382
|
878,495
|
192,154
|
273,548
|
3,217,492
|
2,628,344
|
Income tax expense
|
(244,293)
|
61,128
|
(285,769)
|
(297,033)
|
(89,801)
|
(102,608)
|
(619,863)
|
(338,513)
|
Net income
|
1,908,663
|
1,537,429
|
586,613
|
581,462
|
102,353
|
170,940
|
2,597,629
|
2,289,831
|
|
|
|
|
|
|
|
|
|
Normalized EBITDA
(iii)
|
3,030,676
|
2,832,014
|
1,333,007
|
1,203,368
|
275,012
|
320,789
|
4,638,695
|
4,356,171
|
Exceptional items
|
(2,283)
|
(16,159)
|
(6,149)
|
(12,535)
|
-
|
-
|
(8,432)
|
(28,694)
|
Depreciation. amortization and impairment
|
(642,448)
|
(646,186)
|
(169,849)
|
(156,184)
|
(56,798)
|
(25,200)
|
(869,095)
|
(827,570)
|
Net finance costs
|
(233,279)
|
(694,062)
|
(284,627)
|
(156,154)
|
(26,387)
|
(22,379)
|
(544,293)
|
(872,595)
|
Share of result of joint ventures
|
290
|
694
|
-
|
-
|
327
|
338
|
617
|
1,032
|
Income tax expense
|
(244,293)
|
61,128
|
(285,769)
|
(297,033)
|
(89,801)
|
(102,608)
|
(619,863)
|
(338,513)
|
Net income
|
1,908,663
|
1,537,429
|
586,613
|
581,462
|
102,353
|
170,940
|
2,597,629
|
2,289,831
|
|
|
|
|
|
|
|
|
|
Normalized EBITDA margin in %
|
41.3%
|
38.5%
|
43.1%
|
43.5%
|
22.6%
|
28.5%
|
39.9%
|
38.7%
|
|
|
|
|
|
|
|
|
|
Acquisition of property, plant and equipment
|
333,098
|
328,241
|
118,798
|
132,500
|
20,780
|
37,202
|
472,676
|
497,943
|
|
|
|
|
|
|
|
|
|
|
03/31/2018
|
12/31/2017
|
03/31/2018
|
12/31/2017
|
03/31/2018
|
12/31/2017
|
03/31/2018
|
12/31/2017
|
Segment assets
|
47,534,077
|
48,811,664
|
10,980,054
|
11,558,524
|
10,087,181
|
10,204,929
|
68,601,312
|
70,575,117
|
Intersegment elimination
|
|
|
|
|
|
|
(2,928,341)
|
(3,077,679)
|
Non-segmented assets
|
|
|
|
|
|
|
16,705,974
|
19,354,551
|
Total assets
|
|
|
|
|
|
|
82,378,945
|
86,851,989
|
|
|
|
|
|
|
|
|
|
Segment liabilities
|
16,179,726
|
23,031,617
|
5,023,030
|
6,015,233
|
3,489,045
|
3,700,157
|
24,691,801
|
32,747,007
|
Intersegment elimination
|
|
|
|
|
|
|
(2,928,323)
|
(3,077,693)
|
Non-segmented liabilities
|
|
|
|
|
|
|
60,615,467
|
57,182,675
|
Total liabilities
|
|
|
|
|
|
|
82,378,945
|
86,851,989
|
(i) Latin America – North: includes operations in Brazil, Luxembourg and CAC (El Salvador, Guatemala, Nicaragua, Dominican Republic, Saint Vincent, Dominica, Antigua, Cuba, Barbados and Panama).
(ii) Latin America – South: includes operations in Argentina, Bolivia, Chile, Paraguay and Uruguay.
(iii) Normalized EBITDA is calculated excluding of the net income the following effects: (i) Income tax expense, (iii) Share of results of joint ventures (iii) Net finance result, (iv) Exceptional items, and (v) Depreciation, amortization and impairment of property, plant and equipment.
(b)
Additional information – by Business unit – period ended in:
|
Latin America - north
|
|
CAC
|
Brazil
|
Total
|
|
03/31/2018
|
03/31/2017
|
03/31/2018
|
03/31/2017
|
03/31/2018
|
03/31/2017
|
|
|
|
|
|
|
|
Net sales
|
1,149,722
|
1,057,872
|
6,180,432
|
6,294,194
|
7,330,154
|
7,352,066
|
Cost of sales
|
(488,438)
|
(463,923)
|
(2,349,356)
|
(2,664,494)
|
(2,837,794)
|
(3,128,417)
|
Gross profit
|
661,284
|
593,949
|
3,831,076
|
3,629,700
|
4,492,360
|
4,223,649
|
Distribution expenses
|
(130,669)
|
(126,594)
|
(945,943)
|
(905,460)
|
(1,076,612)
|
(1,032,054)
|
Sales and marketing expenses
|
(131,207)
|
(129,128)
|
(789,034)
|
(788,222)
|
(920,241)
|
(917,350)
|
Administrative expenses
|
(56,637)
|
(60,393)
|
(328,051)
|
(316,257)
|
(384,688)
|
(376,650)
|
Other operating income/(expenses)
|
4,224
|
8,073
|
273,185
|
280,160
|
277,409
|
288,233
|
Exceptional items
|
(605)
|
(10,651)
|
(1,678)
|
(5,508)
|
(2,283)
|
(16,159)
|
Income from operations (EBIT)
|
346,390
|
275,256
|
2,039,555
|
1,894,413
|
2,385,945
|
2,169,669
|
Net finance cost
|
(19,019)
|
(50,091)
|
(214,260)
|
(643,971)
|
(233,279)
|
(694,062)
|
Share of result of joint ventures
|
1,907
|
3,764
|
(1,617)
|
(3,070)
|
290
|
694
|
Income before income tax
|
329,278
|
228,929
|
1,823,678
|
1,247,372
|
2,152,956
|
1,476,301
|
Income tax expense
|
(89,540)
|
(70,837)
|
(154,753)
|
131,965
|
(244,293)
|
61,128
|
Net income
|
239,738
|
158,092
|
1,668,925
|
1,379,337
|
1,908,663
|
1,537,429
|
|
|
|
|
|
|
|
Normalized EBITDA
(i)
|
445,051
|
376,921
|
2,585,625
|
2,455,093
|
3,030,676
|
2,832,014
|
Exceptional items
|
(605)
|
(10,651)
|
(1,678)
|
(5,508)
|
(2,283)
|
(16,159)
|
Depreciation, amortization and impairment
|
(98,056)
|
(91,014)
|
(544,392)
|
(555,172)
|
(642,448)
|
(646,186)
|
Net finance costs
|
(19,019)
|
(50,091)
|
(214,260)
|
(643,971)
|
(233,279)
|
(694,062)
|
Share of result of joint ventures
|
1,907
|
3,764
|
(1,617)
|
(3,070)
|
290
|
694
|
Income tax expense
|
(89,540)
|
(70,837)
|
(154,753)
|
131,965
|
(244,293)
|
61,128
|
Net income
|
239,738
|
158,092
|
1,668,925
|
1,379,337
|
1,908,663
|
1,537,429
|
|
|
|
|
|
|
|
Normalized EBITDA margin in %
|
38.7%
|
35.6%
|
41.8%
|
39.0%
|
41.3%
|
38.5%
|
(i) Normalized EBITDA is calculated excluding of the net income the following effects: (i)
Income tax expense
, (iii)
Share of results of joint ventures
, (iii)
Net finance result
, (iv) Exceptional items, and (v) Depreciation, amortization and impairment of property, plant and equipment.
|
Brazil
|
|
Beer
|
Soft drink and
Non-alcoholic and
non-carbonated
|
Total
|
|
03/31/2018
|
03/31/2017
|
03/31/2018
|
03/31/2017
|
03/31/2018
|
03/31/2017
|
|
|
|
|
|
|
|
Net sales
|
5,315,588
|
5,370,465
|
864,844
|
923,729
|
6,180,432
|
6,294,194
|
Cost of sales
|
(1,882,718)
|
(2,113,911)
|
(466,638)
|
(550,583)
|
(2,349,356)
|
(2,664,494)
|
Gross profit
|
3,432,870
|
3,256,554
|
398,206
|
373,146
|
3,831,076
|
3,629,700
|
Distribution expenses
|
(772,304)
|
(732,017)
|
(173,639)
|
(173,443)
|
(945,943)
|
(905,460)
|
Sales and marketing expenses
|
(744,965)
|
(739,672)
|
(44,069)
|
(48,550)
|
(789,034)
|
(788,222)
|
Administrative expenses
|
(279,283)
|
(272,651)
|
(48,768)
|
(43,606)
|
(328,051)
|
(316,257)
|
Other operating income/(expenses)
|
216,639
|
222,809
|
56,546
|
57,351
|
273,185
|
280,160
|
Exceptional items
|
(1,381)
|
(4,661)
|
(297)
|
(847)
|
(1,678)
|
(5,508)
|
Income from operations (EBIT)
|
1,851,576
|
1,730,362
|
187,979
|
164,051
|
2,039,555
|
1,894,413
|
Net finance cost
|
(214,260)
|
(643,971)
|
-
|
-
|
(214,260)
|
(643,971)
|
Share of result of joint ventures
|
(1,617)
|
(3,070)
|
-
|
-
|
(1,617)
|
(3,070)
|
Income before income tax
|
1,635,699
|
1,083,321
|
187,979
|
164,051
|
1,823,678
|
1,247,372
|
Income tax expense
|
(154,753)
|
131,965
|
-
|
-
|
(154,753)
|
131,965
|
Net income
|
1,480,946
|
1,215,286
|
187,979
|
164,051
|
1,668,925
|
1,379,337
|
|
|
|
|
|
|
|
Normalized EBITDA
(i)
|
2,330,851
|
2,214,933
|
254,774
|
240,160
|
2,585,625
|
2,455,093
|
Exceptional items
|
(1,381)
|
(4,661)
|
(297)
|
(847)
|
(1,678)
|
(5,508)
|
Depreciation, amortization and impairment
|
(477,894)
|
(479,910)
|
(66,498)
|
(75,262)
|
(544,392)
|
(555,172)
|
Net finance costs
|
(214,260)
|
(643,971)
|
-
|
-
|
(214,260)
|
(643,971)
|
Share of result of joint ventures
|
(1,617)
|
(3,070)
|
-
|
-
|
(1,617)
|
(3,070)
|
Income tax expense
|
(154,753)
|
131,965
|
-
|
-
|
(154,753)
|
131,965
|
Net income
|
1,480,946
|
1,215,286
|
187,979
|
164,051
|
1,668,925
|
1,379,337
|
|
|
|
|
|
|
|
Normalized EBITDA margin in %
|
43.8%
|
41.2%
|
29.5%
|
26.0%
|
41.8%
|
39.0%
|
(i) Normalized EBITDA is calculated excluding of the net income the following effects: (i)
Income tax expense
, (iii)
Share of results of joint ventures
, (iii)
Net finance result
, (iv) Exceptional items, and (v) Depreciation, amortization and impairment of property, plant and equipment.
15.
NET SALES
The reconciliation between gross sales and net sales is as follows:
|
03/31/2018
|
03/31/2017
|
|
|
|
Gross sales and/or services
|
17,454,715
|
17,489,216
|
Excise duty
|
(3,732,465)
|
(3,978,052)
|
Discounts
|
(2,082,031)
|
(2,269,359)
|
|
11,640,219
|
11,241,805
|
Services provided by distributors, such as the promotion of our brands and logistics services are considered as expense when separately identifiable.
16.
OTHER OPERATING INCOME / (EXPENSES)
|
03/31/2018
|
03/31/2017
|
Government grants/NPV of long term fiscal incentives
|
194,809
|
221,897
|
(Additions)/Reversals to provisions
|
(6,640)
|
(10,551)
|
Gains/(losses) on disposal of property, plant and equipment, intangible assets and operation in associates
|
(21,928)
|
(5,376)
|
Other operating income/(expenses), net
|
91,319
|
84,856
|
|
257,560
|
290,826
|
Government grants are not recognized until there is reasonable assurance that the Company will meet related conditions and that the grants will be received. Government grants are systematically recognized in income during the periods in which the Company recognizes as expenses the related costs that the grants are intended to offset.
17.
FINANCE COST AND INCOME
(a)
Finance costs
|
03/31/2018
|
03/31/2017
|
Interest expense
|
(348,087)
|
(402,843)
|
Capitalized borrowings
|
20
|
599
|
Net Interest on pension plans
|
(24,482)
|
(24,914)
|
Losses on hedging instruments
|
(263,101)
|
(248,611)
|
Interest on provision for disputes and litigations
|
(29,137)
|
(72,690)
|
Exchange variation
|
(96,162)
|
(87,142)
|
Tax on financial transactions
|
(91,176)
|
(37,969)
|
Bank guarantee expenses
|
(24,560)
|
(21,268)
|
Other financial results
|
(43,149)
|
(101,420)
|
|
(919,834)
|
(996,258)
|
Interest expenses are presented net of the effect of interest rate derivative financial instruments which mitigate Ambev interest rate risk (Note 20 –
Financial instruments and risks
). The interest expense are as follows:
|
03/31/2018
|
03/31/2017
|
Financial liabilities measured at amortized cost
|
(144,437)
|
(115,108)
|
Liabilities at fair value through profit or loss
|
(203,650)
|
(278,416)
|
Fair value hedge - hedged items
|
-
|
(10,111)
|
Fair value hedge - hedging instruments
|
-
|
792
|
|
(348,087)
|
(402,843)
|
(b)
Finance income
|
03/31/2018
|
03/31/2017
|
Interest income
|
103,267
|
108,664
|
Gains on derivative
|
80,642
|
2,010
|
Financial assets at fair value through profit or loss
|
188,762
|
8,742
|
Other financial results
|
2,870
|
4,247
|
|
375,541
|
123,663
|
Interest income arises from the following financial assets:
|
03/31/2018
|
03/31/2017
|
Cash and cash equivalents
|
59,510
|
43,264
|
Investment securities held for trading
|
4,255
|
10,169
|
Other receivables
|
39,502
|
55,231
|
|
103,267
|
108,664
|
18.
INCOME TAX AND SOCIAL CONTRIBUTION
Income taxes reported in the income statement are analyzed as follows:
|
03/31/2018
|
03/31/2017
|
Income tax expense - current
|
(728,053)
|
(681,759)
|
|
|
|
Deferred tax expense on temporary differences
|
168,079
|
454,125
|
Deferred tax over taxes losses carryforwards movements in the current period
|
(59,889)
|
(110,879)
|
Total deferred tax (expense)/income
|
108,190
|
343,246
|
|
|
|
Total income tax expenses
|
(619,863)
|
(338,513)
|
The reconciliation from the weighted nominal to the effective tax rate is summarized as follows:
|
03/31/2018
|
03/31/2017
|
Profit before tax
|
3,217,492
|
2,628,344
|
Adjustment on taxable basis
|
|
|
Non-taxable income
|
(78,250)
|
(104,850)
|
Government grants related to sales taxes
|
(413,734)
|
(434,413)
|
Share of result of joint ventures
|
(617)
|
(1,032)
|
Non-deductible expenses
|
64,542
|
89,995
|
Complement of income tax of foreign subsidiaries due in Brazil
|
27,852
|
22,083
|
Results of intercompany transactions non-taxable/not deductible in Brazil
|
(116,245)
|
12,716
|
|
2,701,040
|
2,212,843
|
Aggregated weighted nominal tax rate
|
30.34%
|
29.62%
|
Taxes payable – nominal rate
|
(819,500)
|
(655,548)
|
Adjustment on tax expense
|
|
|
Regional incentives - income taxes
|
53,460
|
28,141
|
Deductible interest on shareholders' equity
|
299,655
|
284,395
|
Tax savings from goodwill amortization on tax books
|
18,274
|
36,224
|
Withholding tax over undistributed profits
|
(52,960)
|
(51,238)
|
Recognition / write-off of deferred charges on tax losses
|
(28,166)
|
-
|
Others with reduced taxation
|
(90,626)
|
19,513
|
Income tax and social contribution expense
|
(619,863)
|
(338,513)
|
Effective tax rate
|
19.27%
|
12.88%
|
The main events that impacted the effective tax rate in the period were:
§
|
Government subsidy on sales taxes: The tax expense results from the deductibility of investment subsidies at state level. The reduction in this quarter reflects the reality of the operations with finished goods in the units that benefit from the subsidy.
|
|
|
§
|
Deductible interest on shareholders' equity: Under Brazilian law, companies have an option to distribute Interest on Capital (“IOC”), which is deductible for income tax purposes. Until the present time the total deductibility derived impact is R$299,655.
|
|
|
§
|
Results of intercompany transactions taxable/ deductible in Brazil: are a result of foreign exchange fluctuation on mutual contracts that are agreed upon a different currency with foreign subsidiaries. Taking into account the current fluctuation of the Brazilian Real (“BRL”) before other currencies, those results are taxable in Brazil.
|
19.
SHARE-BASED PAYMENTS
There are different stock option and share-based payment programs which allow the employees and senior management from the Company and its subsidiaries to acquire or receive shares
of the Company
. For all stock option programs, the fair value of the shares is estimated at the options grant date, using the “Hull Binomial” pricing model, adjusted to reflect the IFRS 2 requirement that assumptions about forfeiture before the end of the vesting period cannot impact the fair value of the option.
This current model of
stock option, ruled by the Stock Option Plan of the Company (
“
Stock
Option Plan”), includes two types of grants: (I) Grant 1- the beneficiary may allocate 30%, 40%, 60%, 70% or 100% of the amount related to the profit share he received in the year, through the immediate exercise of options, thus acquiring the corresponding shares of the Company, which transfer to third parties or the Company will only be allowed after the
five-year
grace period
counted
from the date of exercise of the options; and (II) Grant 2 - the beneficiary may exercise the options after a
five-year
grace period, for a period of five years.
In addition, the Company has implemented a
Share-Based Payment Plan
(“
Share-Based Plan”)
under which certain employees and members of the management of the Company or its subsidiaries are eligible to receive shares of the Company including in the form of ADR’s. The shares that are subject to the
Share-Based
Plan are designated as "restricted shares" and
their reference
price, when applicable, for the purposes of the
Share-Based
Plan will correspond to the price of the Company's shares in B3 S.A.- Brasil, Bolsa, Balcão, at the trading session immediately prior to the
grant of shares.
Additionally, as a mean of a creating a long term incentive (wealth incentive) for certain senior employees and members of management considered as having “high potential,” the Company grants, under the
Share-Based
Plan,
shares to be delivered in the future divided
in two separate lots – Lot A and Lot B, which will be delivered to the participants of the
relevant
program, subject to maturation periods of five and ten years, respectively.
The weighted average fair value of the options and assumptions used in applying the Company’s option pricing model of 2018 and 2017 grants are as follows:
In R$, except when otherwise indicated
|
03/31/2018
|
(i)
|
12/31/2017
|
(i)
|
|
|
|
|
|
Fair value of options granted
|
6.98
|
|
6.51
|
|
Share price
|
22.35
|
|
19.80
|
|
Exercise price
|
22.35
|
|
19.80
|
|
Expected volatility
|
26.2%
|
|
26.7%
|
|
Vesting year
|
5
|
|
5
|
|
Expected dividends
|
5%
|
|
5%
|
|
Risk-free interest rate
|
9.6%
|
(ii)
|
10.1%
|
(ii)
|
(i)
Information based on weighted average plans granted, except for the expected dividends and risk-free interest rate.
(ii
) The percentages include the grants of stock options and ADR’s during the period, in which the risk-free interest rate of ADR’s are calculated in U.S. dollar.
The total number of outstanding options developed as follows:
Thousand options
|
03/31/2018
|
|
12/31/2017
|
|
|
|
|
Options outstanding at January 1
st
|
135,221
|
|
131,244
|
Options issued during the period
|
3,861
|
|
20,435
|
Options exercised during the period
|
(5,353)
|
|
(13,548)
|
Options forfeited during the period
|
(1,559)
|
|
(2,910)
|
Options outstanding at ended period
|
132,170
|
|
135,221
|
The range of exercise prices of the outstanding options is between R$0.001 (R$0.001 on December 31, 2017) and
R$24.46
(R$26.09 on December 31, 2017) and the weighted average remaining contractual life is approximately
6.42
years (6.40 years on December 31, 2017).
Of the 132,170 thousand outstanding options (135,221 thousand on December 31, 2017), 35,490 thousand options are vested on March 31, 2018 (40,150 thousands on December 31, 2017).
The weighted average exercise price of the options is as follows:
In R$ per share
|
03/31/2018
|
|
12/31/2017
|
|
|
|
|
Options outstanding at January 1
st
|
15.27
|
|
13.87
|
Options issued during the period
|
22.35
|
|
19.82
|
Options forfeited during the period
|
16.96
|
|
17.88
|
Options exercised during the period
|
8.06
|
|
5.81
|
Options outstanding at ended period
|
15.74
|
|
15.27
|
Options exercisable at ended period
|
3.94
|
|
3.78
|
For the options exercised during the period ended March 31,2018, the weighted average share price on the exercise date was R$22.83 (R$18.87 as of December 31, 2017).
During the period, the Company granted 49 thousand (794 thousand on December 31, 2017) deferred stock units related to the exercise of stock options granted in the previous years. These deferred stock units are valued based on the share price of the trading session immediately prior to the stock option grant, representing a fair value of approximately R$1,103 on March 31, 2018 (R$15,193 on December 31, 2017).
Such deferred stock units are subject to a grace period of five years counted from the options date of exercise.
During the period, the Company granted 3,422 thousand restricted shares units under the Share-Based Plan, which are valued based on the share price of the trading session immediately prior to the grant of shares, representing a fair value of approximately R$76,458 on March 31,2018. Such restricted shares units are subject to a grace period of five years counted from the date of grant.
The total number of shares purchased or granted,
as the case may be, under the Stock Option Plan and Share-Based Plan by employees, the delivery of which will be performed in the future under certain conditions (deferred stock and restricted shares), is demonstrated below:
Thousand deferred shares
|
03/31/2018
|
|
12/31/2017
|
|
|
|
|
Deferred shares outstanding at January 1
st
|
16,300
|
|
19,260
|
New deferred shares during the period
|
49
|
|
794
|
Deferred shares granted during the period
|
(3,358)
|
|
(2,874)
|
Deferred shares forfeited during the period
|
(686)
|
|
(880)
|
Deferred shares outstanding at ended period
|
12,305
|
|
16,300
|
Thousand restricted shares
|
03/31/2018
|
|
12/31/2017
|
|
|
|
|
Restricted shares outstanding at January 1st
|
-
|
|
-
|
New restricted shares during the period
|
3,422
|
|
-
|
Restricted shares outstanding at ended period
|
3,422
|
|
-
|
Additionally, certain employees and
managers
of the Company receive
d
options to acquire AB Inbev shares, the compensation cost of which is recognized in the income statement against equity
.
The transactions with
share-based payments described above generated
an expense of R$46,918 (R$55,110
on March 31, 2017),
recorded as administrative expenses.
20.
FINANCIAL
INSTRUMENTS AND RISKS
Risk factors
The
Company is exposed to foreign currency,
interest rate, commodity
price, liquidity and
credit risk in
the ordinary course of business. The Company analyzes
each of these risks both
individually and as a whole to define
strategies to
manage the
economic impact on Company’s
performance
consistent with its Financial
Risk Management Policy.
The Company’s use of derivatives strictly follows
its Financial Risk Management Policy approved by the Board of Directors. The
purpose of the policy is to provide guidelines for the management of financial
risks inherent to the capital markets in which Ambev carries out its operations.
The policy comprises four main aspects: (i) capital structure, financing and
liquidity, (ii) transactional risks related to the business, (iii) financial
statements translation risks and (iv) credit risks of financial counterparties.
The
policy establishes that all the financial assets and liabilities in each
country where Ambev operates must be denominated in their respective local
currencies. The policy also sets forth the procedures and controls needed for
identifying, measuring and minimizing market risks, such as variations in
foreign exchange rates, interest rates and commodities (mainly aluminum, wheat,
corn and sugar) that may affect Ambev’s revenues, costs and/or investment amounts.
The policy states that all the known risks (e.g. foreign currency and interest)
shall be hedged by contracting derivative financial instruments. Existing risks
not yet recorded (e.g. future contracts for the purchase of raw material or
property, plant and equipment) shall be mitigated using projections for the period
necessary for the Company to adapt to the new costs scenario that may vary from
ten to fourteen months, also through the use of derivative financial
instruments. Most of the translation risks are not hedged. Any exception to the
policy must be approved by the Board of Directors.
Derivative financial Instruments
Derivative
financial instruments authorized by the Financial
Risk Management Policy are futures contracts
traded on exchanges, full deliverable forwards, non-deliverable forwards, swaps
and options. At March 31, 2018, the Company and its subsidiaries had no target
forward, swaps with currency verification or any other derivative operations representing
a risk level above the nominal value of their contracts. The derivative
operations are classified by strategies according to their purposes, as
follows:
i) Cash flow hedge derivative
instruments – The highly probable forecast
transactions contracted in order to minimize the Company's exposure to
fluctuations of exchange rates and prices of raw materials, investments,
equipment and services to be procured, protected by cash flow hedges that shall
occur at various different dates during the next fourteen months. Gains and
losses classified as hedging reserve in equity are recognized in the income statement
in the period or periods when the forecast and hedged transaction affects the
income statement.
ii)
Fair value hedge derivative instruments – operations contracted with the
purpose of mitigating the Company’s net indebtedness against foreign exchange and
interest rate risk. Cash net positions and foreign currency debts are
continually assessed for identification of new exposures.
The
results of these operations, measured according to their fair value, are
recognized in financial results.
iii) Net investment
hedge derivative instruments
–
transactions entered
into in order
to minimize exposure of
the exchange differences arising
from conversion of net
investment in the Company's subsidiaries located
abroad for
translation account balance. The effective portion
of the hedge is
allocated to
equity and the ineffectiveness portion is
recorded directly
in financial results.
The following tables summarize the exposure of the
Company that were identified and protected in accordance with the Company's
Risk Policy. The following denominations have been applied:
Operational Hedge: Refers to the exposures arising from
the core business of Ambev, such as: purchase of inputs, purchase of fixed assets
and service contracts linked to foreign currency, which is protected through
the use of derivatives.
Financial Hedge: Refers to the exposures arising from
cash and financing activities, such as: foreign currency cash and foreign
currency debt, which is protected through the use of derivatives.
Investment hedge abroad: Refers mainly to exposures arising
from cash hold in foreign currency in foreign subsidiaries whose functional
currency is different from the consolidation currency.
Investment hedge -
Put option
granted on
subsidiary
: As detailed
in Note 13 (d.4) the Company constituted a liability related to acquisition of
Non-controlling interest in the Dominican Republic operations. This financial
instrument is denominated in Dominican Pesos and is recorded in a Company which
functional currency is the Real. The Company assigned this financial instrument
as a hedging instrument for part of its net assets located in the Dominican
Republic, in such manner the hedge result can be recorded
in other comprehensive income of the group, following the result of the hedged
item.
Transactions protected by
derivative financial instruments in accordance with the Financial Risk
Management Policy
|
|
|
|
|
|
|
03/31/2018
|
|
03/31/2018
|
|
|
|
|
|
|
|
Fair Value
|
|
Gain / (Losses)
|
Exposure
|
|
Risk
|
|
|
Notional
|
|
Assets
|
Liability
|
|
Finance Result
|
Operational Result
|
Equity
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost
|
|
|
(9,811,070)
|
|
9,617,951
|
|
176,258
|
(234,583)
|
|
(267,540)
|
113,238
|
29,321
|
|
|
Commodity
|
(2,441,771)
|
|
2,248,652
|
|
55,238
|
(110,423)
|
|
(14,350)
|
18,689
|
(118,486)
|
|
|
American Dollar
|
(6,878,785)
|
|
6,878,785
|
|
85,329
|
(119,818)
|
|
(253,951)
|
80,337
|
147,333
|
|
|
Euro
|
(106,169)
|
|
106,169
|
|
6,664
|
(1,316)
|
|
(407)
|
1,382
|
4,896
|
|
|
Mexican Pesos
|
(384,345)
|
|
384,345
|
|
29,027
|
(3,026)
|
|
1,168
|
12,830
|
(4,422)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed Assets
|
|
|
(629,884)
|
|
629,884
|
|
2,606
|
(6,230)
|
|
(1,534)
|
-
|
-
|
|
|
American Dollar
|
(579,959)
|
|
579,959
|
|
2,606
|
(5,561)
|
|
(2,014)
|
-
|
-
|
|
|
Euro
|
(49,925)
|
|
49,925
|
|
-
|
(669)
|
|
480
|
-
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expenses
|
|
|
(226,968)
|
|
226,968
|
|
1,260
|
(1,520)
|
|
(520)
|
2,388
|
164
|
|
|
American Dollar
|
(224,648)
|
|
224,648
|
|
1,078
|
(1,441)
|
|
(602)
|
2,555
|
166
|
|
|
Rupee
|
(2,320)
|
|
2,320
|
|
182
|
(79)
|
|
82
|
(167)
|
(2)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash
|
|
|
699,188
|
|
(699,188)
|
|
-
|
(10,145)
|
|
(24,888)
|
-
|
-
|
|
|
American Dollar
|
714,188
|
|
(714,188)
|
|
-
|
(10,134)
|
|
(24,888)
|
-
|
-
|
|
|
Interest rate
|
(15,000)
|
|
15,000
|
|
-
|
(11)
|
|
-
|
-
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debts
|
|
|
(2,210,139)
|
|
1,649,009
|
|
99,229
|
(45,667)
|
|
28,410
|
-
|
-
|
|
|
American Dollar
|
(1,871,920)
|
|
1,310,790
|
|
59,230
|
(44,469)
|
|
17,874
|
-
|
-
|
|
|
Interest rate
|
(338,219)
|
|
338,219
|
|
39,999
|
(1,198)
|
|
10,536
|
-
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity Instrument
|
|
|
(2,782,522)
|
|
748,907
|
|
128,594
|
-
|
|
70,106
|
-
|
-
|
|
|
Stock exchange prices
|
(2,782,522)
|
|
748,907
|
|
128,594
|
-
|
|
70,106
|
-
|
-
|
As of March 31, 2018
|
|
|
(14,961,395)
|
|
12,173,531
|
|
407,947
|
(298,145)
|
|
(195,966)
|
115,626
|
29,485
|
|
|
|
|
|
|
|
Fair Value
|
|
Gain / (Losses)
|
Exposure
|
|
Risk
|
|
|
Notional
|
|
Assets
|
Liability
|
|
Finance Result
|
Operational Result
|
Equity
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost
|
|
|
(9,742,375)
|
|
9,318,936
|
|
283,692
|
(189,997)
|
|
(290,899)
|
(123,591)
|
29,637
|
|
|
Commodity
|
(2,378,747)
|
|
1,955,308
|
|
166,623
|
(70,709)
|
|
(368)
|
44,706
|
(1,860)
|
|
|
American Dollar
|
(6,879,106)
|
|
6,879,106
|
|
86,283
|
(93,397)
|
|
(282,631)
|
(155,930)
|
30,487
|
|
|
Euro
|
(82,906)
|
|
82,906
|
|
3,473
|
(659)
|
|
402
|
(9,935)
|
6,527
|
|
|
Mexican Pesos
|
(401,616)
|
|
401,616
|
|
27,313
|
(25,232)
|
|
(8,302)
|
(2,432)
|
(5,517)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed Assets
|
|
|
(579,426)
|
|
579,426
|
|
1,874
|
(10,799)
|
|
(1,900)
|
-
|
-
|
|
|
American Dollar
|
(531,858)
|
|
531,858
|
|
1,759
|
(10,799)
|
|
(1,335)
|
-
|
-
|
|
|
Euro
|
(47,568)
|
|
47,568
|
|
115
|
-
|
|
(565)
|
-
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expenses
|
|
|
(177,721)
|
|
177,721
|
|
494
|
(1,786)
|
|
(2,433)
|
118
|
243
|
|
|
American Dollar
|
(169,199)
|
|
169,199
|
|
314
|
(1,617)
|
|
(2,408)
|
-
|
-
|
|
|
Rupee
|
(8,522)
|
|
8,522
|
|
180
|
(169)
|
|
(25)
|
118
|
243
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash
|
|
|
(1,328,291)
|
|
1,328,291
|
|
-
|
(13,116)
|
|
15,225
|
-
|
-
|
|
|
American Dollar
|
(1,313,291)
|
|
1,313,291
|
|
-
|
(13,106)
|
|
15,220
|
-
|
-
|
|
|
Interest rate
|
(15,000)
|
|
15,000
|
|
-
|
(10)
|
|
5
|
-
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debts
|
|
|
(919,426)
|
|
356,858
|
|
29,963
|
(1,791)
|
|
(72,301)
|
-
|
-
|
|
|
American Dollar
|
(562,568)
|
|
-
|
|
-
|
-
|
|
(75,103)
|
-
|
-
|
|
|
Interest rate
|
(356,858)
|
|
356,858
|
|
29,963
|
(1,791)
|
|
2,802
|
-
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity Instrument
|
|
|
(2,347,931)
|
|
677,006
|
|
69,201
|
(35)
|
|
-
|
-
|
-
|
|
|
American Dollar
|
(2,347,931)
|
|
677,006
|
|
69,201
|
(35)
|
|
-
|
-
|
-
|
Total
|
|
|
(15,095,170)
|
|
12,438,238
|
|
385,224
|
(217,524)
|
|
(352,308)
|
(123,473)
|
29,880
|
I.
Market risk
a.1) Foreign currency risk
The Company is exposed to foreign currency risk on borrowings, investments, purchases, dividends and/or interest expense/income whenever they are denominated in currency other than the functional currency of the subsidiary. The main derivatives financial instruments used to manage foreign currency risk are futures contracts, swaps, options, non deliverable forwards and full deliverable forwards.
a.2) Commodity Risk
A significant portion of the Company inputs comprises commodities, which historically have experienced substantial price fluctuations. The Company therefore uses both fixed price purchasing contracts and derivative financial instruments to minimize its exposure to commodity price volatility. The Company has important exposures to the following commodities: aluminum, sugar, wheat and corn. These derivative financial instruments have been designated as cash flow hedges.
a.3) Interest rate risk
The Company applies a dynamic interest rate hedging approach whereby the target mix between fixed and floating rate debt is reviewed periodically. The purpose of the Company’s policy is to achieve an optimal balance between cost of funding and volatility of financial results, taking into account market conditions as well as the Company’s overall business strategy and this strategy is reviewed periodically.
The table below demonstrates the Company’s exposure related to debts, before and after interest rates hedging strategy.
|
03/31/2018
|
|
Pre - Hedge
|
|
Post - Hedge
|
|
Interest rate
|
Amount
|
|
Interest rate
|
Amount
|
Brazilian Real
|
6.6%
|
665,649
|
|
6.0%
|
362,260
|
Working capital in Argentinean peso
|
51.7%
|
5
|
|
51.7%
|
5
|
Dominican Peso
|
9.4%
|
185,514
|
|
9.4%
|
185,514
|
American Dollar
|
3.8%
|
19,718
|
|
3.8%
|
19,718
|
Guatemala´s Quetzal
|
7.8%
|
10,290
|
|
7.8%
|
10,290
|
Interest rate pre-set
|
|
881,176
|
|
|
577,787
|
|
|
|
|
|
|
|
|
|
|
|
|
Brazilian Real
|
9.2%
|
355,852
|
|
6.8%
|
1,988,761
|
American Dollar
|
2.4%
|
1,891,007
|
|
2.4%
|
561,487
|
Canadian Dollar
|
2.2%
|
1,339,747
|
|
2.2%
|
1,339,747
|
Interest rate post fixed
|
|
3,586,606
|
|
|
3,889,995
|
|
12/31/2017
|
|
Pre - Hedge
|
|
Post - Hedge
|
|
Interest rate
|
Amount
|
|
Interest rate
|
Amount
|
Brazilian Real
|
6.4%
|
682,578
|
|
5.9%
|
370,851
|
Working capital in Argentinean peso
|
31.0%
|
1,792
|
|
31.0%
|
1,792
|
Dominican Peso
|
9.3%
|
188,791
|
|
9.3%
|
188,792
|
American Dollar
|
3.8%
|
22,901
|
|
3.8%
|
22,901
|
Guatemala´s Quetzal
|
7.8%
|
10,307
|
|
7.8%
|
10,307
|
Interest rate pre-set
|
|
906,369
|
|
|
594,643
|
|
|
|
|
|
|
|
|
|
|
|
|
Brazilian Real
|
9.2%
|
402,348
|
|
7.6%
|
714,073
|
American Dollar
|
2.7%
|
555,282
|
|
2.7%
|
555,283
|
Canadian Dollar
|
2.0%
|
685,881
|
|
2.0%
|
685,881
|
Barbadian Dollar
|
2.3%
|
4,962
|
|
2.3%
|
4,962
|
Interest rate post fixed
|
|
1,648,473
|
|
|
1,960,199
|
Sensitivity analysis
The Company mitigates risks arising from non-derivative financial assets and liabilities substantially, through derivative financial instruments. In this context, the Company has identified the main risk factors that may generate losses from these derivative financial instruments and has developed a sensitivity analysis based on three scenarios, which may impact the Company’s future results and/or cash flow, as described below:
1 – Probable scenario: Management expectations of deterioration in each transaction’s main risk factor. To measure the possible effects on the results of derivative transactions, the Company uses parametric Value at Risk – VaR. is a statistical measure developed through estimates of standard deviation and correlation between the returns of several risk factors. This model results in the loss limit expected for an asset over a certain time period and confidence interval. Under this methodology, we used the potential exposure of each financial instrument, a range of 95% and horizon of 21 days after March 31, 2018 for the calculation, which are presented in the module.
2 – Adverse scenario: 25% deterioration in each transaction’s main risk factor as compared to the level observed on March 31, 2018.
3 – Remote scenario: 50% deterioration in each transaction’s main risk factor as compared to the level observed on March 31, 2018.
Transaction
|
Risk
|
Fair Value
|
Probable scenario
|
Adverse scenario
|
Remote
scenario
|
|
|
|
|
|
|
Commodities hedge
|
Decrease on commodities price
|
(55,185)
|
(241,110)
|
(617,348)
|
(1,179,511)
|
Input purchase
|
55,185
|
258,472
|
665,628
|
1,276,071
|
Foreign exchange hedge
|
Foreign currency decrease
|
(3,140)
|
(104,006)
|
(1,845,464)
|
(3,687,788)
|
Input purchase
|
3,140
|
104,006
|
1,845,464
|
3,687,788
|
Costs effects
|
|
-
|
17,362
|
48,280
|
96,560
|
|
|
|
|
|
|
Foreign exchange hedge
|
Foreign currency decrease
|
(3,624)
|
(12,041)
|
(161,095)
|
(318,566)
|
Capex Purchase
|
3,624
|
12,041
|
161,095
|
318,566
|
Fixed assets effects
|
|
-
|
-
|
-
|
-
|
|
|
|
|
|
|
Foreign exchange hedge
|
Foreign currency decrease
|
(260)
|
(2,948)
|
(57,002)
|
(113,744)
|
Expenses
|
260
|
2,948
|
57,002
|
113,744
|
Expenses effects
|
|
-
|
-
|
-
|
-
|
|
|
|
|
|
|
Hedge cambial
|
Foreign currency increase
|
(10,134)
|
(19,155)
|
(188,681)
|
(367,228)
|
Cash
|
10,134
|
19,155
|
188,681
|
367,228
|
Interest Hedge
|
Decrease in interest rate
|
(11)
|
(423)
|
(2,075)
|
(2,435)
|
Interest revenue
|
11
|
423
|
2,075
|
2,435
|
Cash effects
|
|
-
|
-
|
-
|
-
|
|
|
|
|
|
|
Hedge cambial
|
Foreign currency decrease
|
14,761
|
(7,799)
|
(312,937)
|
(640,634)
|
Cash
|
(14,761)
|
17,457
|
453,219
|
921,199
|
Interest Hedge
|
Increase in interest rate
|
38,801
|
29,514
|
(101,900)
|
(119,579)
|
Interest expenses
|
(38,801)
|
(29,514)
|
101,900
|
119,579
|
Debt effects
|
|
-
|
9,658
|
140,282
|
280,565
|
|
|
|
|
|
|
Equity Instrument Hedge
|
Stock exchange price decrease
|
128,594
|
112,238
|
(58,633)
|
(245,860)
|
Expenses
|
(128,594)
|
(69,757)
|
567,036
|
1,262,667
|
Equity effects
|
|
-
|
42,481
|
508,403
|
1,016,807
|
|
|
-
|
69,501
|
696,965
|
1,393,932
|
As of March 31, 2018 the Notional and
Fair Value amounts per instrument and maturity were as follows:
|
|
Notional Value
|
Exposure
|
Risk
|
2018
|
2019
|
2020
|
2021
|
>2021
|
Total
|
|
|
|
|
|
|
|
|
Cost
|
|
8,347,365
|
1,270,586
|
-
|
-
|
-
|
9,617,951
|
|
Commodity
|
1,675,245
|
573,407
|
-
|
-
|
-
|
2,248,652
|
|
American Dollar
|
6,316,320
|
562,465
|
-
|
-
|
-
|
6,878,785
|
|
Euro
|
88,406
|
17,763
|
-
|
-
|
-
|
106,169
|
|
Mexican Peso
|
267,394
|
116,951
|
-
|
-
|
-
|
384,345
|
|
|
|
|
|
|
|
|
Fixed asset
|
|
580,374
|
49,510
|
-
|
-
|
-
|
629,884
|
|
American Dollar
|
530,449
|
49,510
|
-
|
-
|
-
|
579,959
|
|
Euro
|
49,925
|
-
|
-
|
-
|
-
|
49,925
|
|
|
|
|
|
|
|
|
Expenses
|
|
218,055
|
8,913
|
-
|
-
|
-
|
226,968
|
|
American Dollar
|
213,681
|
10,967
|
-
|
-
|
-
|
224,648
|
|
Rupee
|
4,374
|
(2,054)
|
-
|
-
|
-
|
2,320
|
|
|
|
|
|
|
|
|
Cash
|
|
(714,188)
|
-
|
15,000
|
-
|
-
|
(699,188)
|
|
American Dollar
|
(714,188)
|
-
|
-
|
-
|
-
|
(714,188)
|
|
Interest rate
|
-
|
-
|
15,000
|
-
|
-
|
15,000
|
|
|
|
|
|
|
|
|
Debt
|
|
1,310,790
|
-
|
-
|
110,000
|
228,219
|
1,649,009
|
|
American Dollar
|
1,310,790
|
-
|
-
|
-
|
-
|
1,310,790
|
|
Interest rate
|
-
|
-
|
-
|
110,000
|
228,219
|
338,219
|
|
|
|
|
|
|
|
|
Equity Instrument
|
|
677,946
|
70,961
|
-
|
-
|
-
|
748,907
|
|
Stock prices
|
677,946
|
70,961
|
-
|
-
|
-
|
748,907
|
|
|
10,420,342
|
1,399,970
|
15,000
|
110,000
|
228,219
|
12,173,531
|
|
|
Fair Value
|
Exposure
|
Risk
|
2018
|
2019
|
2020
|
2021
|
>2021
|
Total
|
|
|
|
|
|
|
|
|
Cost
|
|
(20,927)
|
(37,398)
|
-
|
-
|
-
|
(58,325)
|
|
Commodity
|
(41,277)
|
(13,908)
|
-
|
-
|
-
|
(55,185)
|
|
American Dollar
|
(6,604)
|
(27,885)
|
-
|
-
|
-
|
(34,489)
|
|
Euro
|
5,267
|
81
|
-
|
-
|
-
|
5,348
|
|
Mexican Peso
|
21,687
|
4,314
|
-
|
-
|
-
|
26,001
|
|
|
|
|
|
|
|
|
Fixed asset
|
|
(3,526)
|
(98)
|
-
|
-
|
-
|
(3,624)
|
|
American Dollar
|
(2,857)
|
(98)
|
-
|
-
|
-
|
(2,955)
|
|
Euro
|
(669)
|
-
|
-
|
-
|
-
|
(669)
|
|
|
|
|
|
|
|
|
Expenses
|
|
(348)
|
88
|
-
|
-
|
-
|
(260)
|
|
American Dollar
|
(459)
|
96
|
-
|
-
|
-
|
(363)
|
|
Rupee
|
111
|
(8)
|
-
|
-
|
-
|
103
|
|
|
|
|
|
|
|
|
Cash
|
|
(10,134)
|
-
|
(11)
|
-
|
-
|
(10,145)
|
|
American Dollar
|
(10,134)
|
-
|
-
|
-
|
-
|
(10,134)
|
|
Interest rate
|
-
|
-
|
(11)
|
-
|
-
|
(11)
|
|
|
|
|
|
|
|
|
Debt
|
|
14,761
|
-
|
-
|
28,890
|
9,911
|
53,562
|
|
American Dollar
|
14,761
|
-
|
-
|
-
|
-
|
14,761
|
|
Interest rate
|
-
|
-
|
-
|
28,890
|
9,911
|
38,801
|
|
|
|
|
|
|
|
|
Equity Instrument
|
|
126,559
|
2,035
|
-
|
-
|
-
|
128,594
|
|
Stock prices
|
126,559
|
2,035
|
-
|
-
|
-
|
128,594
|
|
|
106,385
|
(35,373)
|
(11)
|
28,890
|
9,911
|
109,802
|
II.
Credit Risk
Concentration of credit risk on trade
receivables
A
substantial part of the Company’s sales is made to distributors, supermarkets and
retailers, within a broad distribution network.
Credit risk is reduced because of the widespread number of customers and
control procedures used to monitor risk. Historically, the Company has not
experienced significant losses on receivables from customers.
Concentration of credit risk on
counterpart
In
order to minimize the credit risk of its investments, the Company has adopted
procedures for the allocation of cash and investments, taking into
consideration limits and credit analysis of financial institutions, avoiding
credit concentration, i.e., the credit risk is monitored and minimized to the
extent that negotiations are carried out only with a select group of highly
rated counterparties.
The
selection process of financial institutions authorized to operate as the
Company’s counterparty is set forth in our Credit Risk Policy. This Credit Risk
Policy establishes maximum limits of exposure to each counterparty based on the
risk rating and on each counterparty's capitalization.
In
order to minimize the risk of credit with its counterparties on significant
derivative transactions, the Company has adopted bilateral “trigger” clauses. According
to these clauses, where the fair value of an operation exceeds a percentage of
its notional value (generally between 10% and 15%), the debtor settles the
difference in favor of the creditor.
As of March 31, 2018, the Company
held its main short-term investments with the following financial institutions:
Banco do Brasil, Bradesco, Bank Mendes Gans, Caixa Econômica Federal, Citibank,
Itaú, JP Morgan Chase, Merrill Lynch, Santander e Toronto Dominion Bank. The
Company had derivative agreements with the following financial institutions: Banco
Bisa, Barclays, BNB, BNP Paribas, Bradesco, Citibank, Deutsche Bank, Itaú,
Goldman Sachs, JP Morgan Chase, Macquarie, Merrill Lynch, Morgan Stanley,
Santander, ScotiaBank e TD Securities.
The carrying amount of cash and cash equivalents,
investment securities, trade receivables excluding prepaid expenses, recoverable
taxes and derivative financial instruments are disclosed net of provisions for
impairment and represents the maximum exposure of credit risks of March 31,
2018. There was no concentration of credit risk with any counterparties as of March
31, 2018.
III.
Liquidity
Risk
The
Company believes that
cash flows from
operating activities,
cash and cash equivalents
and short-term investments, together with
the derivative financial
instruments and access to
loan facilities are sufficient to finance capital expenditures, financial liabilities and dividend
payments in the future.
IV.
Equity
price risk
Through
the equity swap transaction approved on May 16
th
, 2017 and December
21,2017 by the Board of Directors of Ambev (see
Note 1 -
Corporate information
),
the Company, or its controlled entity, will receive the price variation related
to its shares traded on the stock exchange or ADRs, neutralizing the possible
effects of the stock prices’ oscillation in view of the share-based payment of
the Company. As these derivative instruments are not characterized as hedge
accounting they were not therefore designated to any hedge.
In
March 31, 2018, an exposure equivalent to R$2.3 billion in AmBev’s shares (or
ADR’s) was partially hedged, resulting in a gain in income statement of R$ 70,106.
V.
Capital management
Ambev
is continuously optimizing its capital structure targeting to maximize
shareholder value while keeping the desired financial flexibility to execute
the strategic projects. Besides the statutory minimum equity funding
requirements that apply to the Company’s subsidiaries in the different
countries, Ambev is not subject to any externally imposed capital requirements.
When analyzing its capital structure, the Company uses the same debt ratings and
capital classifications as applied in the Company’s interim financial
statements.
Financial
instruments
(a)
Financial instruments categories
Management of
the financial
instruments held by the
Company is effected
through operational strategies
and internal controls
to assure liquidity, profitability
and transaction security.
Financial instruments transactions are regularly reviewed for the effectiveness of
the risk exposure that management intends to
cover (foreign exchange, interest
rate, etc.).
The
table below shows all financial instruments recognized in the interim financial
statements, segregated
by category:
|
03/31/2018
|
|
Fair value through other comprehensive income
|
Amortized cost
|
Fair value through profit or loss
|
Total
|
Financial assets
|
|
|
|
|
Cash and cash equivalents
|
1,873,172
|
6,080,305
|
-
|
7,953,477
|
Trade receivables excluding prepaid expenses
|
-
|
5,466,353
|
-
|
5,466,353
|
Investment securities
|
-
|
143,481
|
12,229
|
155,710
|
Financial instruments derivatives
|
-
|
-
|
227,823
|
227,823
|
Derivatives hedge
|
-
|
-
|
180,124
|
180,124
|
Total
|
1,873,172
|
11,690,139
|
420,176
|
13,983,487
|
|
|
|
|
|
Financial liabilities
|
|
|
|
|
Trade payables and put option granted on subsidiary
and other liabilities
|
-
|
12,220,492
|
1,981,449
|
14,201,941
|
Financial instruments derivatives
|
-
|
-
|
58,490
|
58,490
|
Derivatives hedge
|
-
|
-
|
239,655
|
239,655
|
Interest-bearning loans and borrowings
|
-
|
4,467,655
|
-
|
4,467,655
|
Total
|
-
|
16,688,147
|
2,279,594
|
18,967,741
|
|
12/31/2017
|
|
Fair value through other comprehensive income
|
Amortized cost
|
Fair value through profit or loss
|
Total
|
Financial assets
|
|
|
|
|
Cash and cash equivalents
|
3,081,755
|
7,272,772
|
-
|
10,354,527
|
Trade receivables excluding prepaid expenses
|
-
|
7,505,038
|
-
|
7,505,038
|
Investment securities
|
-
|
121,956
|
11,883
|
133,839
|
Financial instruments derivatives
|
-
|
-
|
100,140
|
100,140
|
Derivatives hedge
|
-
|
-
|
285,084
|
285,084
|
Total
|
3,081,755
|
14,899,766
|
397,107
|
18,378,628
|
|
|
|
|
|
Financial liabilities
|
|
|
|
|
Trade payables and put option granted on subsidiary
and other liabilities
|
-
|
13,501,952
|
5,764,057
|
19,266,009
|
Financial instruments derivatives
|
-
|
-
|
16,125
|
16,125
|
Derivatives hedge
|
-
|
-
|
201,399
|
201,399
|
Interest-bearning loans and borrowings
|
-
|
2,553,050
|
-
|
2,553,050
|
Total
|
-
|
16,055,002
|
5,981,581
|
22,036,583
|
(b)
Classification of financial instruments by type of fair value measurement
IFRS
13 defines fair value as the price that would be received to sell an asset or
paid to transfer a liability in an orderly transaction between market
participants at the measurement date.
Also
pursuant to IFRS 13, financial instruments measured at fair value shall be
classified within the following categories
:
Level 1 – quoted prices
(unadjusted) in active markets for identical assets or liabilities that the
entity can access at the measurement date valuation;
Level
2 – inputs other than quoted prices included within Level 1 that are observable
for the asset or liability, either directly or indirectly; and
Level
3 – unobservable inputs for the asset or liability.
|
03/31/2018
|
|
12/31/2017
|
|
|
|
|
|
|
|
|
|
|
|
Level 1
|
Level 2
|
Level 3
|
Total
|
|
Level 1
|
Level 2
|
Level 3
|
Total
|
Financial assets
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Financial asset at fair value through other
comprehensive income
|
1,873,172
|
-
|
-
|
1,873,172
|
|
3,081,755
|
-
|
-
|
3,081,755
|
Financial asset at fair value through profit or loss
|
12,229
|
-
|
-
|
12,229
|
|
11,883
|
-
|
-
|
11,883
|
Derivatives assets at fair value through profit or
loss
|
-
|
227,823
|
-
|
227,823
|
|
114
|
100,026
|
-
|
100,140
|
Derivatives - operational hedge
|
14,727
|
165,397
|
-
|
180,124
|
|
4,795
|
280,289
|
-
|
285,084
|
|
1,900,128
|
393,220
|
-
|
2,293,348
|
|
3,098,547
|
380,315
|
-
|
3,478,862
|
Financial liabilities
|
|
|
|
|
|
|
|
|
|
Financial liabilities at fair value through profit and
loss
(i)
|
-
|
-
|
1,981,449
|
1,981,449
|
|
-
|
-
|
5,764,057
|
5,764,057
|
Derivatives liabilities at fair value through profit
or loss
|
1,980
|
56,510
|
-
|
58,490
|
|
1,733
|
14,392
|
-
|
16,125
|
Derivatives - operational hedge
|
60,175
|
179,480
|
-
|
239,655
|
|
58,356
|
143,043
|
-
|
201,399
|
|
62,155
|
235,990
|
1,981,449
|
2,279,594
|
|
60,089
|
157,435
|
5,764,057
|
5,981,581
|
(i)
Refers to the put option granted on subsidiary as described in Note 13 d(4).
Reconciliation
of changes in the categorization of Level 3
Financial liabilities at December 31, 2017
|
5,764,057
|
Acquisition of investments
|
(3,619,186)
|
Total gains and losses in the period
|
(163,422)
|
Losses recognized in net income
|
49,096
|
Gain recognized in equity
|
(212,518)
|
Financial liabilities at March 31, 2018
(i)
|
1,981,449
|
(i)
The liability was recorded under “Trade payables and put option granted on
subsidiary and other liabilities” on the balance sheet.
(c) Fair value of
financial liabilities measured at amortized cost
The
Company’s liabilities, interest-bearing loans and borrowings, trade payables
excluding tax payables, are recorded at amortized cost according to the
effective rate method, plus indexation and foreign exchange gains/losses, based
on closing indices for each exercise.
The
financial instruments recorded at amortized cost are similar to the fair value
and are not material for disclosure.
Calculation of fair value of
derivatives
The
Company measures derivative financial instruments by calculating their present
value, through the use of market curves that impact the instrument on the
computation dates. In the case of swaps, both the asset and the liability
positions are estimated independently and brought to present value, where the
difference between the result of the asset and liability amount generates the
swaps market value. For the traded derivative financial instruments, the fair
value is calculated according to the adjusted exchange-listed price.
Margins
given in guarantee
In
order to comply with the guarantee requirements of the derivative exchanges and/or
counterparties in certain operations with derivative financial
instruments, as of March 31, 2018 the Company held R$606,873
in highly liquid financial investments or in cash,
classified as cash and cash equivalents and investment securities (R$608,279 on
December 31, 2017).
Offsetting
of financial assets and liabilities
For
financial assets and liabilities subject to settlement agreements by the net or
similar agreements, each agreement between the Company and the counterparty allows
this type of settlement when both parties make this option. In the absence of
such election, the assets and liabilities will be settled by their amounts, but
each party shall have the option to settle on net, in case of default by the
counterparty.
21.
COLLATERAL
AND CONTRACTUAL COMMITMENTS WITH SUPLLIERS, ADVANCES FROM CUSTOMERS AND OTHER
|
03/31/2018
|
12/31/2017
|
|
|
|
Collateral given for own liabilities
|
606,873
|
606,279
|
Other commitments
|
825,339
|
842,733
|
|
1,432,212
|
1,449,012
|
|
|
|
Commitments with suppliers
|
13,273,067
|
11,096,305
|
|
13,273,067
|
11,096,305
|
The
collateral provided for liabilities totaled approximately R$1,432,212 on March
31, 2018 (R$1,449,012 on December 31, 2017), including R$558,095
(R$551,008 on December 31, 2017) of cash guarantees.
The deposits in cash used as guarantees are presented as part of other assets.
To meet the guarantees required by derivative exchanges and/or counterparties
contracted in certain derivative financial instrument transactions, Ambev maintained
on March 31, 2018, R$606,873 (R$606,279 on December
31, 2017) in highly liquid financial investments
or in cash, classified as cash and cash equivalents
and investment securities (Note 20 –
Financial
instruments and risks
).
Most of the balance relates to commitments with
suppliers of packaging.
Future
contractual commitments on
March 31, 2018
a
nd
December
31, 2017 are as follows:
|
03/31/2018
|
12/31/2017
|
|
|
|
Less than 1 year
|
3,346,038
|
3,812,794
|
Between 1 and 2 years
|
3,166,991
|
2,995,742
|
More than 2 years
|
6,760,038
|
4,287,769
|
|
13,273,067
|
11,096,305
|
22.
CONTINGENT
LIABILITY
The Company has contingent liabilities
related to lawsuits arising from its normal course of business.
Due to their nature, such
legal proceedings involve
certain
uncertainties including, but not limited to, court and
tribunals rulings, negotiations between affected parties and governmental actions,
and as a consequence the Company’s management cannot estimate the likely timing
of resolution of these matters
at this stage
.
Contingent liabilities with a probable
likelihood of loss are fully recorded as liabilities (Note 12 –
Provisions
).
Additionally,
the Company has lawsuits related to tax, civil and labor for which the
likelihood of loss is classified as possible by management:
|
03/31/2018
|
12/31/2017
|
|
|
|
IRPJ and CSLL
|
32,765,060
|
31,757,317
|
ICMS and IPI
|
20,813,947
|
19,805,529
|
PIS and COFINS
|
3,520,660
|
3,485,242
|
Labor
|
296,074
|
287,087
|
Civil
|
4,006,361
|
4,071,540
|
Others
|
1,147,050
|
1,113,442
|
|
62,549,152
|
60,520,157
|
Principal lawsuits with a likelihood of possible
loss:
There was no relevant changes in the main cases
with possible chances of loss when compared to the period ending in 31st
December 2017, except for monetary inflation and the case described below:
ICMS
ICMS-ST Trigger
Over the years, the Company received tax
assessments relating to supposed ICMS differences considered due in the tax
substitution system when the price of the products sold reaches levels close to
or above the fixed price table basis established by certain States, cases in
which the State tax authorities understand that the calculation basis should be
based on a value-added percentage over the actual prices and not the fixed table
price. The Company is challenging these assessments at administrative and
judicial courts.
Among other similar cases, in 2016, the Company
received three assessments issued by the State of Minas Gerais, in the original
amount of R$1.4 billion. In the first quarter of 2018 these cases had an
unfavorable final administrative decision. Ambev will now seek recourse at the
judicial level.
In 2017, Ambev received new relevant tax
assessments issued by the State of Rio de Janeiro which amounts to the original
amount of R$900 million. The Company filed defenses against these charges and
currently awaits decision by the Administrative Court of the State Rio de
Janeiro.
Considering these new tax assessments and other
received during 2017, Ambev management estimates the total possible losses
related to this issue to be approximately R$6.6 billion (R$5.8 billion as of 31
December 2017). Ambev has recorded provisions in the total amount of R$7.6
million in relation to the proceedings for which it considers the chances of
loss to be probable, due to specific procedural issues.
Contingent
assets
According to IAS 37, contingent assets are not recorded in consolidated
financial statements, except when the realization of income is virtually
certain.
The Company and its subsidiaries applied for the refund of the PIS and
COFINS collected with the inclusion of the ICMS in their taxable basis from
1990 onwards. The relevant amounts are still being.
23.
NON-CASH
ITEMS
The Company carried out the following investment and
financing activities not involving cash:
|
03/31/2018
|
03/31/2017
|
Cash financing cost other than interests
|
(74,009)
|
6,118
|
Fair value of options granted on
subsidiary
|
129,405
|
-
|
Others
|
114
|
-
|
24.
RELATED
PARTIES
Policies and practices regarding the realization of
transactions with related parties
The Company adopts corporate governance practices and
those recommended and/or required by the applicable law.
Under the Company’s by laws the Board of Directors is
responsible for approving any transaction or agreements between the Company and/or
any of its subsidiaries, directors and/or shareholders (including shareholders,
direct or indirect shareholders of the Company).
The Antitrust Compliance and Related Parties Committee of the Company is required to advise the Board of Directors of the Company in matters related to transactions with related parties.
Management is prohibited from interfering in any transaction in which conflict exists, even in theory, with the Company interests. It is also not permitted to interfere in decisions of any other management member, requiring documentation in the Minutes of Meeting of the Board any decision to abstain from the specific deliberation.
The Company’s guidelines with related parties follow reasonable or commutative terms, similar to those prevailing in the market or under which the Company would contract similar transactions with third parties. These are clearly disclosed in the financial statements as reflected in written contracts.
Transactions with management members:
In addition to short-term benefits (primarily salaries), the management members are entitled to participate in Stock Option Plan (Note 19 –
Share-based payments
).
Total expenses related to the Company’s management members are as follows:
|
03/31/2018
|
03/31/2017
|
|
|
|
Short-term benefits
(i)
|
5,119
|
5,032
|
Share-based payments
(ii)
|
9,871
|
9,182
|
Total key management remuneration
|
14,990
|
14,214
|
(i) These correspond substantially to management’s salaries and profit sharing (including performance bonuses
).
(ii) These correspond to the compensation cost of stock options and restricted stocks granted to management. These amounts exclude remuneration paid to members of the Fiscal Council
.
Excluding the above mentioned plan (Note 19 –
Share-based payments
), the Company no longer has any type of transaction with the Management members or pending balances receivable or payable in its balance sheet.
Transactions with the Company's shareholders:
a) Medical, dental and other benefits
The Fundação Antonio e Helena Zerrenner Instituição Nacional de Beneficiência (“Fundação Zerrenner) is one of Ambev’s shareholders, and at March 31, 2018 held 10.2% of total share capital. Fundação Zerrenner is also an independent legal entity whose main goal is to provide Ambev’s employees, both active and retirees, with health care and dental assistance, technical and superior education courses, facilities for assisting elderly people, through direct initiatives or through financial assistance agreements with other entities. On March 31, 2018 and December 31, 2017, actuarial responsibilities related to the benefits provided directly by Fundação Zerrenner are fully funded by plan assets, held for that purpose, which significantly exceeds the liabilities at these dates. Ambev recognizes the assets (prepaid expenses) of this plan to the extent of amounts from economic benefits available to the Company, arising from reimbursements or future contributions reduction.
The expenses incurred by Fundação Zerrenner in providing these benefits totaled
R$76,351
(R$64,660 on March 31, 2017), of which
R$66,174
and
R$10,177
related to active employees and retirees
respectively
(R$56,052 and R$8,608 on March 31, 2017 related to active employees and retirees
respectively).
b) Leasing
The Ambev, through its subsidiary BSA (labeling), has an asset leasing agreement with Fundação Zerrenner, for R$63,328 for ten years, maturing on March 31, 2018.
c) Leasing – Ambev head office
Ambev has a leasing agreement of two commercial sets with Fundação Zerrenner in the annual amount of R$3,255,
maturing on January, 2020.
d) Licensing agreement
The Company maintains a licensing agreement with Anheuser-Busch, Inc., to produce, bottle, sell and distribute Budweiser products in Brazil, Canada, and sales and distribution agreements of Budweiser products in Guatemala, Dominican Republic, Paraguay, El Salvador, Nicaragua, Uruguay and Chile. In addition, the Company produces and distributes Stella Artois products under license to ABI in Brazil and Canada and, by means of a license granted to ABI, it also distributes Brahma’s product in the United States and several countries such as the United Kingdom, Spain, Sweden, Finland and Greece. The amount recorded was R$341 (R$358 on March 31, 2017) and R$82,174 (R$61,620 on March 31, 2017) as licensing income and expense, respectively.
Ambev has licensing agreements with the Group Modelo, subsidiaries of ABI, for to import, promote and sell products Corona (
Corona Extra, Corona Light, Coronita, Pacifico and Negra Modelo
) in countries of the Latin America and the Canada.
Transactions with related parties
|
|
|
|
03/31/2018
|
Current
|
Trade receivables
(i)
|
Other Trade receivables
(i)
|
Trade payables
(i)
|
Other Trade payables
(i)
|
AB InBev
|
36,067
|
-
|
(324,133)
|
-
|
AB Procurement
|
342
|
-
|
-
|
-
|
AB Services
|
30,449
|
-
|
(4,828)
|
-
|
AB USA
|
46,983
|
5,410
|
(210,633)
|
-
|
Ambrew
|
-
|
-
|
(1)
|
-
|
Cervecería Modelo
|
101,471
|
-
|
(535,342)
|
-
|
Inbev
|
870
|
30,144
|
(35,877)
|
-
|
ITW International
|
-
|
-
|
(213,542)
|
(58,270)
|
Panama Holding
|
25,716
|
-
|
(7,768)
|
-
|
Others
|
24,478
|
482
|
(93,836)
|
-
|
|
266,376
|
36,036
|
(1,425,960)
|
(58,270)
|
(i) The amount represents the marketing operations (purchase and sale) and the reimbursement between the companies of the group.
|
|
|
|
|
|
12/31/2017
|
Current
|
Trade receivables
(i)
|
Other Trade receivables
(i)
|
Trade payables
(i)
|
Other Trade payables
(i)
|
Borrowings and interest payable
|
Dividends payables
(i)
|
AB InBev
|
1,159
|
33,639
|
(363,048)
|
(1,733)
|
-
|
-
|
AB Procurement
|
8,860
|
129
|
-
|
-
|
-
|
-
|
AB Services
|
802
|
29,100
|
3
|
(6,127)
|
-
|
-
|
AB USA
|
14,136
|
16,349
|
(375,734)
|
(8,732)
|
-
|
-
|
Ambrew
|
-
|
-
|
-
|
-
|
-
|
(89,968)
|
Cervecería Modelo
|
91,629
|
5,767
|
(589,292)
|
(59,710)
|
-
|
-
|
Inbev
|
101
|
23,779
|
(33,775)
|
-
|
-
|
-
|
ITW International
|
-
|
-
|
-
|
(212,527)
|
(48,330)
|
(590,937)
|
Panama Holding
|
-
|
20,324
|
-
|
(4,006)
|
-
|
-
|
Others
|
13,944
|
8,612
|
(73,653)
|
(3,029)
|
-
|
-
|
|
130,631
|
137,699
|
(1,435,499)
|
(295,864)
|
(48,330)
|
(680,905)
|
(i) The amount represents the marketing operations (purchase and sale) and the reimbursement between the companies of the group.
The tables below represent the transactions with related parties, recognized in the income statement:
|
|
|
|
03/31/2018
|
Company
|
Buying / Service fees / Rentals
|
Sales
|
Royalties
|
Net Finance Cost
|
AB Procurement
|
-
|
4,409
|
-
|
-
|
AB USA
|
(48,386)
|
10,638
|
(62,043)
|
-
|
Ambev Peru
|
-
|
5
|
-
|
-
|
Cervecería Modelo
|
(171,573)
|
22
|
(7,030)
|
-
|
Inbev
|
(19,178)
|
-
|
-
|
-
|
Others
|
(20,482)
|
2,057
|
(12,760)
|
(9,346)
|
|
(259,619)
|
17,131
|
(81,833)
|
(9,346)
|
|
|
|
|
03/31/2017
|
Company
|
Buying / Service fees / Rentals
|
Sales
|
Royalties
|
Net Finance Cost
|
AB InBev
|
43
|
-
|
(8,553)
|
-
|
AB USA
|
(74,729)
|
12,015
|
(47,109)
|
-
|
Ambev Peru
|
(4,921)
|
952
|
-
|
-
|
Cervecería Modelo
|
(83,739)
|
28
|
(5,344)
|
-
|
InBev
|
(13,989)
|
-
|
-
|
-
|
Others
|
(17,290)
|
607
|
(256)
|
824
|
|
(194,625)
|
13,602
|
(61,262)
|
824
|
Denomination used in the tables above
:
AB InBev Procurement GmbH (“AB Procurement”)
|
Ambrew S.A. (“Ambrew”)
|
Anheuser-Busch InBev N.V. (“AB InBev”)
|
Anheuser-Busch Inbev Services LLC (“AB Services”)
|
Anheuser-Busch Inbev USA LLC (“AB USA”)
|
Cervecería Modelo de Mexico S. de R.L. de C.V. (“Cervecería Modelo”)
|
Cerveceria Nacional - Panamá (“Panama Holding”)
|
Compañia Cervecera Ambev Peru S.A.C. (“Ambev Peru”)
|
Inbev Belgium N.V. (“Inbev”)
|
Interbrew International B.V. (“ITW International”)
|
25.
EVENTS AFTER THE REPORTING PERIOD
As disclosed in Note 1 -
Corporate information
in September 2017, Quilmes, a subsidiary of Ambev, entered into an agreement whereby AB InBev will grant a perpetual license to Quilmes in Argentina for Budweiser and other North American brands upon the recovery of the distribution rights by AB InBev from Compañia Cervecerías Unidas S.A. - CCU. The agreement also foresees the transfer by AB InBev to Quilmes of Cerveceria Argentina Sociedad Anonima Isenbeck and the transfer by Quilmes of some Argentinean brands (Norte, Iguana and Baltica) and related business assets along with USD 50 million. The closing of the transaction was subject to the approval of the Argentinean antitrust authority and others usual closing conditions. The approval of the Argentinean antitrust authority was granted on April 27, 2018 and the transaction closed on May 02, 2018. The company estimates positive impact of R$57 million on profit and loss as result of the accounting practice involving transactions under common control.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Date: May 23, 2018
|
|
|
|
AMBEV S.A.
|
|
|
|
|
By:
|
/s/
Ricardo Rittes de Oliveira Silva
|
|
Ricardo Rittes de Oliveira Silva
Chief Financial and Investor Relations Officer
|
Ambev (NYSE:ABEV)
Historical Stock Chart
From Aug 2024 to Sep 2024
Ambev (NYSE:ABEV)
Historical Stock Chart
From Sep 2023 to Sep 2024